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This study measures  the monetary  value households  place on preventing  malaria  in
Tigray,  Ethiopia. We estimate  a household  demand  function  for a hypothetical  malaria
vaccine  and calculate  willingness  to pay to prevent  malaria as the area  beneath  this
demand  function  to the left of household  size. Willingness  to pay is contrasted  with the
traditional  costs of illness--the  medical  costs and time lost due to malaria.
Our results  indicate  that the value of preventing  malaria  with vaccines  is about 36
USD  per household  per year  or about 15  percent of imputed  annual  household  income.
This is, on average,  about two or three times the expected  household  cost of illness.
While  the benefits from preventing  malaria  are large, the fact that vaccine  demand  is
price inelastic  suggests  that it will be difficult  to achieve  significant  market  penetration
unless  the vaccine  is subsidized.
Similar  results are obtained  for insecticide-treated  bednets. Our estimates  of
household  demand  functions  for bednets  suggest  that at a price that might permit  cost
recovery  (6 USD per bednet),  only one-third  of the population  of a 200-person  village
would  sleep under  bednets.
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viI. INTRODUCTION
Motivation and Purpose
The purpose of this study is to measure the monetary value households place on
preventing malaria in Tigray, a region in the north of Ethiopia.  To persons familiar with
malaria, the value of preventing it might seem self-evident. There are, however, at least
two reasons why it is important to attach a dollar value to reductions in the disease
(Gomes, 1993). The first is that, both within the health sector and outside of that sector,
malaria prevention programs must compete with other programs for funds. Unless one
can attach a dollar value to the benefits of  preventing malaria, it is difficult for malaria
prevention programs to be compared with other programs whose benefits are more easily
monetized and to compete with them for funding.  The second reason is that, in order to
design and implement malaria prevention programs, it is necessary to measure what
people are willing to pay for them.
To elaborate on the first point, the value of preventing malaria has typically been
equated with the economic losses ("costs of illness") associated with the disease-the
value of lost productivity plus medical costs.  Economic losses, however, fail to capture
the pain and suffering associated with malaria, and tend to place a low value on
preventing the disease in children and the elderly.  Previous studies suggest that the value
of preventing malaria-what  people are willing to pay to prevent the disease-may  be
larger than the economic losses associated with malaria (Whittington et al., 1996). We
examine this rigorously to determine whether the private benefits of malaria control
programs are larger than previously thought.
The first goal of our research is to measure what people in the Tigray region of
Ethiopia would pay to prevent malaria in their households, and to contrast these estimates
with the economic losses associated with malaria in the region.  In order to measure what
a household in Tigray would pay to prevent malaria we asked the household head (or
spouse) whether he or she would purchase hypothetical malaria vaccines for persons in
the family, at a stated price.  The advantage of using a hypothetical vaccine is that it
should capture all components of a household's willingness to pay to prevent malaria.  In
-1I-the health economics literature, the value of avoiding illness is the sum of the various
categories of damages associated with illness. Morbidity (1) reduces the time that a
household spends on productive activities; (2) may necessitate medical expenditures; (3)
may reduce leisure time; (4) may lead to expenditures to prevent illness; and (5) often
yields disutility because of the pain and inconvenience it causes.  If a respondent could
purchase a vaccine that would prevent a household member from contracting malaria, the
household could avoid all five components of the damages associated with morbidity
from malaria.  The vaccine would also eliminate risk of death from the disease.
Household demand for a hypothetical vaccine thus captures all components of the value
of avoiding malaria.
A second goal of the research is to compare the value of avoiding malaria with the
traditional costs of illness, which capture only components (I) and (2) of the morbidity
damages caused by illness. In order to compare the two measures, we asked people to
recall the most recent malaria episode that (a) they experienced, and (b) that one of their
children experienced, and then elicited the various components of the cost of illness.
A third goal of the research is to estimate what people would pay for an actual
malaria prevention program-the  use of impregnated bednets.  Knowing what fraction of
a population would purchase bednets at various prices is essential to the design of a
bednet control program.  In designing such a program one must balance the goals of cost
recovery-which  is necessary for a program to be self-sustaining-against  the arguments
for government subsidization of the program because of the externalities associated with
the control of infectious disease. Knowing what percent of the population would
purchase bednets at prices in the neighborhood of replacement cost allows a policy maker
to calculate how large the bednet subsidy must be in order to ensure participation in such
a program of any desired fraction of the population.
Organization of the Report
The remainder of this report has three parts.  Part II (Research Design) begins
with a description of the questionnaire design and the study area.  It then describes the
characteristics of the study population and their experience with malaria.  We go on to
calculate the costs of illness associated with the disease.  This is followed by a formal
model of a household's  demand for a good (e.g., a vaccine or a bednet) that reduces time
-2 -spent ill with malaria.  We use this model to derive an expression for a household's
willingness to pay (WTP) to prevent malaria, which could be accomplished by
purchasing vaccines for all family members. This model also yields an expression for the
costs of illness (COI). Part III of the report contains empirical estimates of household
demand functions for vaccines and for bednets.  We present estimates of a household
demand function for a malaria vaccine and use it to calculate WTP for malaria
prevention.  We then contrast these values with the traditional costs of illness.  This
section concludes with estimates of the demand for insecticide-treated bednets. Part IV
of the report summarizes our findings and offers some concluding remarks.
- 3 -II. RESEARCH  DESIGN
Questionnaire  Design
A three-part survey instrument was developed to measure both the COI associated
with malaria and WTP for malaria prevention.  (The questionnaire is contained in
APPENDIX I.)1 The first part of the survey asked questions about a household's  current
health status, knowledge of malaria, and past expenditures on malaria prevention and
treatment.  The second part presented the respondent with one of two contingent
valuation scenarios--a hypothetical vaccine scenario or a bednet scenario.  The third
section of the questionnaire requested information on the socioeconomic characteristics
of the household members, including education, income, assets, occupation, and housing
construction.
Cost of Illness Questions
To measure COI, respondents were asked a series of questions about their most
recent episode of malaria during the last two years.  This included questions about the
length and severity of the illness as well as questions about treatment sought and the costs
of treatment.  It also included questions about the time others spent caring for the
respondent when he was ill and about intra-household labor substitution in response to
the respondent's lost work time.  Similarly, to measure COI for children and teenagers,
respondents were asked about the most recent malaria episode experienced within the last
two years by either a child or a teenager in the household.  This was followed by
questions about treatment, treatment costs, caretakers' time, and intra-household labor
substitution.
The Vaccine Scenario
The hypothetical vaccine scenario began by emphasizing that such a vaccine is
not currently and might never be available.  The enumerator described a hypothetical
vaccine to the respondent, available as either a pill or injection, which would prevent the
recipient from contracting malaria for one year. The scenario checked respondent
' The questionnaire,  translated  into Tigrigna,  was pretested  prior to administration.  The questionnaire  was
back-translated  into English  by a second  interpreter  to check  for inconsistencies  and inaccuracies  in the
local  language  version  of the survey  instrument.  A summary  of responses  to the questionnaire  is available
from  the authors  upon  request.
- 4 -understanding of the benefits of the vaccine, and provided reminders of substitute goods
and the budget constraint.  It was also emphasized that a separate vaccine would need to
be purchased for each member of the household in order to protect them from getting
malaria for one year. The respondent was asked whether he would purchase one or more
hypothetical vaccines at one of five randomly assigned prices.  The lowest price was Birr
5 (0.8 USD) and the highest price Birr 200 (32 USD). 2 If the respondent answered 'yes'
to the original choice question, he was then asked how many hypothetical vaccines would
be purchased and to whom they would be given (e.g. adults, teenagers, children).
The Bednet Scenario
A separate sample of respondents received an insecticide-treated bednet (ITN)
contingent valuation scenario.  The bednet scenario coupled an explanation of how using
a bednet reduces the probability of contracting malaria with an actual demonstration of a
double-size polyester bednet impregnated with 1 percent Deltamethrin.  This scenario
also checked respondent understanding of how the bednet works, and provided reminders
of substitute goods and budget constraints.  Respondents were then presented with
information about the costs of annual re-impregnation of an ITN over its 4-year expected
life and were told that they could spread payments for the bednets over 4 months.
The respondent was offered the opportunity to purchase one or more bednets at
one of five randomly assigned prices.  Prices per bednet ranged from a low of Birr 8 (1.3
USD) to a high of Birr 100 (16 USD), with Birr 40 (6.4 USD) as the middle price.  The
highest price, which is lower than the highest price charged for the hypothetical vaccine,
is based on an estimate of the maximum amount that one could conceivably charge for
full cost recovery of an imported ITN.  As with the hypothetical vaccine scenario, if the
respondent answered 'yes'  to this choice question, he was asked how many bednets
would be purchased and for whom in the household they would be used (e.g. adults,
teenagers, and children).
Choice of Study Area and Villages
Our survey was conducted in January of 1997. It was administered by 18 local
interviewers, all of whom were secondary school graduates.  Interviewers received two
2  IUSD = Birr 6.3.
-5-weeks of training in survey administration from the authors, with the help of local
translators.  The interviewers were directed by three field supervisors, who were affiliated
with Mekelle College.
The survey was conducted in the Tembien sector of Tigray region in northern
Ethiopia. We selected two districts (Tangua Abergelle and Kola Tembien) and then chose
18 villages in the 2 districts.  The choice of villages was designed to provide some
variation in malaria incidence.  Because no official statistics on incidence were available,
we used information on chloroquine distribution and village altitude as proxies for
incidence. Chloroquine is the most widely used treatment for malaria in Tigray and
figures on distribution are available from the Tigray Regional Malaria Control District.
Mosquitoes are more likely to be present at lower than at higher altitudes, so villages
were selected at altitudes varying from 1,000 to 2,000 meters.  Twelve of the villages
received the vaccine scenario and six the bednet scenario.
Our goal was to interview 50 households in each of the 18 study villages.
Random sampling within each village was difficult because up-to-date household lists did
not exist.  Each interviewer was placed at a different location in the village and instructed
to walk in a specified direction, interviewing every other household.  To simplify the
logistics of the fieldwork and to avoid spreading confusion in a village when respondents
talked to one another, all households in the same village received the same scenario
(vaccines or bednets).
A total of 889 field interviews were completed; however, 41 respondents (4.6
percent of our sample) were not familiar with malaria.  These households were dropped
from the sample, leaving 569 respondents who were offered the hypothetical vaccine
scenario and 279 respondents who were offered the bednet scenario.  Approximately 114
interviews were completed for each of the five hypothetical vaccine prices and 56 for
each of the five ITN prices (see Table 1).
Characteristics of the Sample Population
Economic Characteristics
The primary activity in Tembien is subsistence agriculture, with the main crops
being sorghum, teff, maize, finger millet, wheat and legumes.  Seventy percent of
households reported their main occupation as farming; ninety percent of households said
- 6 -that they grow some crops. The combination of rainfed agriculture and unreliable rainfall
(550-650 mm per year), however, results in low yields. The mean annual value of crop
production for households that reported some agricultural output was Birr 658 (104
USD).
This was supplemented in most cases by income from livestock, especially cattle
and goats.  Livestock are also a form of investment.  Oxen are the main energy source for
cultivation and threshing, and donkeys are the main means by which produce is
transported to local markets.  In our sample, 55 percent of households owned at least one
cow, 70 percent at least one ox and 34 percent at least one donkey.  For households
owning some livestock, the mean values of livestock holdings are presented in Table 2.
Although there are few off-farm income earning opportunities, 55 percent of
households who answered the question "What was the off-farm income of all members of
this household last year?" reported positive earnings. Mean earnings, for households who
reported positive earnings, were Birr 558 (89 USD).
To compute household income, we added the value of off-farm earnings, crop
production and the annualized value of livestock holdings.  Figure 1 presents the
cumulative distribution of income for the sample.  Mean household income is Birr 1,387
(220 USD) and median income is Birr 1,157 (183 USD).  Figure 2 plots the percent of
total income held by various fractions of the population (a Lorenz Curve); for example,
the bottom 20 percent of families receive 4 percent of total income.  The shape of this
curve is consistent with Lorenz Curves for other developing countries.
Family Composition and Education
The average household in our sample consisted of two adults, two children and
one teenager (see Table 3).  Seventy-eight percent of households included both a husband
and wife, while 20 percent were headed by single females.  A typical household lived in a
walled compound containing two single-room stone dwellings, one for sleeping and one
for cooking. The mean respondent age was 42, with men being slightly above the mean
and women being slightly below it.  Formal education is rare:  three-quarters of our
respondents had never been to school.  Ten percent could read a newspaper with
difficulty, while thirteen percent could easily read a newspaper.
- 7 -Incidence of Malaria
Malaria is endemic in Tembien.  Transmission follows a seasonal pattern, with
peak transmission occurring at the end of the rainy season (i.e., October through
November), and, to a lesser extent, during the rainy season (i.e., June through
September).  Both Plasmodiumfalciparum  and Plasmodium vivax are present, with
Plasmodiumfalciparum  predominating (Ghebreyesus, 1996). Government malaria
control activities include spraying in outbreak areas, particularly in the early part of the
peak transmission season; encouraging environmental control by communities, such as
draining marshes and filling in ditches having standing water; and training volunteer
community health workers to recognize and treat malaria with chloroquine.
Most respondents were very familiar with the disease.  Sixty-eight percent named
mosquitoes as one of the ways in which malaria is transmitted, and 98 percent identified
fever or shivering, or a combination of the two, as symptoms of malaria.  Seventy-six
percent said that taking chloroquine is one of the best ways to cure someone who is sick
with malaria. 3 Most respondents (84 percent) drained areas near their home of standing
water to prevent transmission of the disease.
Official statistics on malaria incidence in Tembien do not exist; however, data are
available on the number of people receiving chloroquine from community health
workers.  Since community health workers treat malaria preemptively (microscopic
facilities are found only at major health centers), these data measure malaria incidence
with error.  Despite this limitation, the seasonal pattern of malaria treatment fits the
expected seasonal variation in malaria very well (Byass, 1995).
Table 4 summarizes self-reported malaria incidence in our sample.  The disease is
widespread, with 78 percent of respondents reporting that they have had the disease at
least once in their lifetime.  Incidence is fairly evenly distributed across household
members.  In the last two years, 58 percent of our respondents reported having had
malaria at least once, 53 percent reported that at least one other adult in their household
had malaria, and 49 percent reported that at least one teenager or child in their household
had malaria.  Seven percent of our sample said that someone in their family had ever died
of malaria.
3 Chloroquine,  however,  is rarely  used as a form of prophylaxis. Only  7 percent of respondents  took
chloroquine  to prevent  malaria.
-8  -Respondents who had the disease at least once in the last two years reported an
average of 2.7 and a median of 2 episodes (or 1.3 and 1 per year). The average is skewed
upward by 22 respondents who reported an unusually high number of episodes (7 or
more) in the last two years.  Such high responses could be accurate, but they might be
attributed to a lack of understanding of the question or to the respondent confusing
malaria with another febrile illness.  If these observations are dropped from the sample,
the average number of episodes falls to 0.9 per year, which is closer to the sample median
of 1 episode per year. 4 In addition to the respondent, on average 1.5 other adults and 2
children per household had the disease in the last two years.
At least two caveats are in order here. First, the malaria incidence in Table 4 is
self-reported.  It is well-known that self-diagnoses may confuse malaria with other febrile
illnesses. To deal with this issue we report separate Cost of Illness information for the
131 respondents who said that their malaria was diagnosed with a medical test. 5 Second,
our recall period (two years) is an extremely long one.  While respondents might
reasonably be expected to recall whether or not they had malaria over this period, the
details of a particular episode may be unreliable from the perspective of measuring Cost
of Illness. 6 To investigate this possibility we computed Cost of Illness estimates for
malaria episodes that occurred between 2 and 4 months prior to the interview.  Average
Cost of Illness per episode, for adults and children, was 10 percent lower for the "short
recall" sub-samnple  than for the sample as a whole.
Cost of Illness Estimates
Before turning to a formal model of household demand for vaccines or bednets, we
present estimates of the costs of illness associated with the malaria episodes experienced
by households in our sample.  (The details of our computations appear in an appendix
4 Inspection  of the data reveals  that these  22 respondents  did not give  unusual answers  to the other  survey
questions  about malaria. It would,  therefore,  appear  that  their responses  may be the result of a lack of
understanding  of the specific  question. For this reason,  we did not drop these  respondents  from the sample.
5 Respondents  were asked if they had ever  had malaria  and,  if so,  how they knew  this. We shall  refer  to
respondents  who said their  malaria  was diagnosed  by a medical  test as respondents  whose  malaria  was ever
diagnosed  by a medical  test, since  we do not know if the test pertained  to their most  recent episode  of
malaria.
6 We argue,  however,  that  the respondent's  recollection  of his last episode  is relevant  to his decision  to
purchase  vaccines.  We therefore  use self-reported  Cost of Illness  as a check  on the validity  of willingness
to pay for vaccines.
9-from the authors.)  We use these estimates below to test the internal validity of
willingness to pay responses.
In the medical economics literature the Cost of Illness (COI) is the sum of the
costs of medical treatment (the "diretIt"  costs of illness) and the value of productive time
lost due to illness (the 'indirect" costs of illness). Depending on the context, costs may
be computed as either private costs or social costs.  Private medical costs, for example,
would include only the costs actually incurred by the sick person.  These might fall short
of social costs if, for example, the government subsidized the cost of medical care.  In
what follows, we compute the private costs of illness for the households in our sample.
We compute a per episode COI that reflects the costs of the most recent malaria
episode experienced during the past two years for the respondent and a child/teenager in
his household.  We then multiply these costs by the number of episodes experienced by
all family members during the last two years (and then divide by 2) to derive an annual
household COI. These calculations are performed for all households in our sample, and
for the sub-sample of households in which the respondent's malaria was ever confirmed
by a medical test.7 As noted above, respondents whose malaria was ever confirmed by a
medical test, report, on average, shorter episodes than our entire sample. 8
Direct Costs of Illness
Our respondents reported that about 88 percent of malaria episodes were treated.
Among treated cases of malaria, more than 89 percent were treated in a clinic or by a
community health worker.  Further, in about 60 percent of cases, respondents received
9 chloroquine.
The direct costs of illness (COI), shown in Table 5, are the out-of-pocket
expenditures for seeing a health practitioner, for medicine, and for transportation to
receive health care.  All components of the direct COI are highest for adults.  For the
entire sample, the average direct COI for adults is Birr 10 (1.6 USD); for teens it is Birr 7
(1.1 USD), and for children it is Birr 5 (0.8 USD).  Costs for each age category are higher
7 In each  case we have eliminated  households  whose  duration  of illness  was greater  than the ninety-fifth
percentile  of the sample  distrib-ation.
8Persons  wishing  to compare  our estimates  of the cost  of illness  with  those from other studies  may  wish to
focus  on this sub-group.
9In  11  percent of cases  respondents  could  not name the medication  received. In 10  percent of cases,
respondents  received  quinine,  and  in 1.4  percent  of cases,  fansidar.
- 10 -for households in which the respondent's  malaria was ever clinically confirmed.1 0 These
costs represent only the private costs of treatment and do not include the social costs of
health care subsidies provided in many parts of Tigray.  These subsidies include the free
provision of both community health worker services and chloroquine.
Indirect Cost of Illness
The indirect costs of illness include the productive time lost by malaria patients,
substitute laborers, and caretakers who did not perform their usual household activities.
These time costs are the sum of three items.  The first is the number of workdays that the
malaria patient loses when ill.  The second is the net time lost by a person who foregoes
his own duties to substitute for the malaria patient at work. This time may be negative
(i.e., it may reduce total time lost) if, for example, the substitute laborer gave up his
leisure time.  The third item is the workdays a caretaker missed while caring for the ill
household member. 1  '  The average number of workdays lost per malaria episode are
shown in Table 6.
In 90 percent of malaria episodes, the respondent was unable to work.  Intra-
household labor substitution occurred in over two-thirds of these episodes.  When
substitution occurred, our findings indicate that, on average, it yielded a net gain in
productivity.  Over 70 percent of respondents' episodes, however, led to productivity
losses from caretaking duties. This pattern is similar for the "medical test" sub-sample;
however, the average number of workdays lost per episode is lower, for each age
category, in this sub-group.
A measure of the monetary value of lost labor is needed to calculate the indirect
COI in monetary terms.  Most cost-of-illness studies assume that daily productivity is
equal to the market wage rate, or some fraction thereof.  This assumption is tenuous in
Tigray, where labor markets are poorly developed, and farming is the primary occupation
of most households.  The absence of market wages plus the seasonal variability in the
10  It should  be noted  that the sub-sample  of households  whose malaria  was confirmed  by a medical  test is,
on average,  better  educated  than our entire  sample.
I  We assume  that all substitute  labor  and caretaking  is intra-household.  This is a reasonable  assumption
given  that the basic farming  unit is the household  (REST, 1995).
- 11 -marginal productivity of on-farm labor makes it difficult to derive measures of daily
productivity.
Since data are unavailable to estimate the daily productivity of agricultural workers,
daily productivity is estimated by assuming that it is some fraction of the average daily
wage for a healthy, unskilled worker.  Our "high productivity" assumption equates adult
productivity with the daily wage.  Our "low productivity" assumption assumes
productivity is half of the daily wage.  Measuring lost productivity is further complicated
by the fact that it is necessary to make assumptions about the productivity of teenagers
and children relative to adults. We assume that a teenager's daily agricultural
productivity is one-half of an adult's, and a child's daily productivity is one-quarter of an
adult's.12
Total COIper Episode
Table 7 summarizes total COI per episode for both productivity assumptions. Total
COI per episode is lowest for children and almost equivalent for adults and teenagers.
On average, the COIper  episode for the entire sample ranges from Birr 46 to 151 (7 to 24
USD) for adults, Birr 41 to 145 (7 to 23 USD) for teenagers, and Birr 23 to 78 (4 to 12
USD) for children.  The upper range of these estimates is about 1/3 lower for the sub-
sample of households in which the respondent's malaria was ever clinically confirmed.
Annual household COI, based on all households, including those with no malaria
episodes, is reported in Table 8.  Average annual household COI ranges from Birr 196
(31 USD) using high productivity assumptions to Birr 58 (9 USD) using low productivity
assumptions.  Annual household COI averages Birr 103 (17 USD) if an adult's time is
valued at 75 percent of the daily wage for unskilled labor.
Household Demand for a Malaria Vaccine
This section begins with a formal model of household demand for preventive
medical care that is standard in the health economics literature (Grossman, 1972).  The
12 In Tigray,  adult  men and women  are responsible  for most of the household  activities,  including  grinding,
food preparation,  childcare,  and agricultural  activities. Teenagers  assist  in household  activities,  especially
water fetching,  fuel collection,  livestock  herding, and  some agricultural  activities. Children  mainly  herd
livestock,  collect  fuel,  and may assist  with  other  agricultural  activities  if necessary  (REST,1995).
- 12  -model is used to derive a demand function for a hypothetical malaria vaccine, which can
be used to estimate a household's WTP for malaria prevention.
A Model of the Demandfor Health-Related Goods
The traditional model of demand for health-related goods (Grossman, 1972)
assumes that a household receives utility from consumption (X) and leisure time (L) and
disutility from time spent ill (S).13 Using subscripts to represent the value of each
variable to family member, i= 1, ...,n,  and assuming  n  family members, household
utility is given by
(1= u(X1,...,X,,  Ll..4,L,  Sl . S'a,  Z).  (1)
The vector Z  represents taste variables that affect the weight the household places on the
consumption of children v. adults, and on health v. other goods. Z  might include the
education level of the head of household, or the head's age and gender.
Time spent ill is, in turn, a function of the preventive care, Ai, and medical
treatment, Mi, that each person receives.  How effective these inputs are depends, of
course, on individual characteristics, HR. These would include baseline healLh  and genetic
predisposition to disease. In the case of malaria, time spent ill also depends on the
prevalence of the vector (endemicity), E.
S1 =s(Aj,M1 ,H,,E),  i=-,...n  (2)
The amounts of preventive care, medical care and other goods that each person
consumes are constrained by the household's  budget. Specifically, total expenditure on
these three goods cannot exceed the household's income,
n  n  n  n
I  +  w,(T-L  ,-SS,)  Xi  +PaAi  + pmJM,
i~~~~~~~~~~~~~~1  ~~~~~~~~~~~~(31)
where I  is household non-earned income, the wi's are the values of income (per unit
time) generated by each family member, and  Jw 1 (T-Li-Sd is household earned income.
(T is total time available.)  The first term on the right-hand side of (3) is household
expenditure on non-health goods, whose price is set equal to 1. The second tvrrn
13We use bold uppercase letters to represent vectors.
- 13 -represents expenditures on preventive care, with price pa.  The last term represents
expenditure on medical care, whose price is Pm.
The head of household selects values of X, L, A and M to maximize household
utility subject to the budget constraint and to the health production functions.  This yields
a household demand function for preventive care A * =  I  Ai  that in general depends on
non-wage income, wages, prices, household characteristics, health characteristics of
family members, and the prevalence of malaria,
,4  -g(I,  w, p"  PM Z, H,E)  (4)
Applicability of the Model to Northern Ethiopia
To apply this model to the demand for malaria prevention in Ethiopia, we
interpret Si as the amount of time person  i  is likely to spend ill with malaria over a year.
While this is uncertain before the fact, we do not explicitly model the uncertainty
associated with the disease. We argue that in cases where morbidity occurs regularly,
such as diarrheal disease, acute respiratory infection, or seasonal malaria, it is appropriate
to use a model of choice under certainty. 
14 Such a model would not be appropriate if
morbidity were infrequent (e.g., a heart attack or stroke) or likely to result in death.  Risk
of death from malaria in Tigray is low, relative to risk of death from other causes.  In
Tigray, 8 persons out of every 10,000 die each year from malaria (Ethiopian Ministry of
Health, 1996). This implies that, an on average, one person per year would be likely to
die of malaria in one of our study villages.  By contrast, risk of death from other causes is
16 per 1,000 people.15
One difficulty in applying the traditional household production model to an
agricultural economy lies in measuring the productivity of each household member (wi).
If each family member worked outside the home, wi would be measured by the wage rate.
If family members work on a family farm, one could replace the household's income by
14This is the standard  practice  in  the profession.  See, for example,  Freeman  (1993).
15Risk of death is, of course,  higher  among children  than adults. We acknowledge  that respondents  may
consider the possibility  that their children may die of malaria, and that this may provide a motive for
buying  them a malaria  vaccine.
- 14 -an agricultural production function, in which output depends on the time input of each
family member.  This does not really solve the problem, however, since we do not have
data to estimate such a production function.  The reality is that obtaining values of
individuals' time is a difficult empirical task.  Moreover, such values are likely to vary
with the season of the year; in Tigray, a person's time is more valuable during planting
and harvest seasons and less valuable at other times.  In spite of these difficulties, we
believe that this model captures important aspects of the demand for health in Tigray.
Willingness to Pay for Malaria Prevention
In our survey, the most complete form of preventive care offered to households
was a hypothetical malaria vaccine. Households were told that the vaccine would prevent
each person who received it from contracting malaria for one year.  It is, therefore, the
case that Si = 0  if the vaccine is purchased.  How many vaccines a household would
choose to buy depends, of course, on the price of the vaccine, and upon the household's
income.  The demand curve pictured in Figure 3 represents the number of vaccines a
household would purchase as a function of price, holding income constant.  The demand
curve may also be interpreted as the household's marginal willingness to pay curve for
additional vaccines.  That is, the monetary value shown on the demand curve above each
quantity is the most the household would pay for that unit of the good.
Because the hypothetical vaccine offers total protection against malaria, the value
to a household of preventing malaria is the value it attaches to having  n  vaccines (i.e.,
one for each family member), which would protect all members of the household from
malaria for one year. The household's maximum willingness to pay for  n  vaccines is the
area under the household's  demand (marginal willingness to pay) curve from  0 to  n;
i.e., the shaded area in Figure 3.  We define this to be the value to a household of totally
preventing malaria (WTP for total prevention) and, in Part III, calculate it for each
household in our study.'6
An interesting question is how WTP for total prevention compares with the Cost
of Illness--the value of productivity losses and medical expenditures that the household
would incur if it did not purchase the vaccine. In the notation of the model, the expected
COI for the household over a year is
16 We note that the demand curves for poor households may reach the x-axis before  n.  For these
households, WTP for prevention is the entire area under the demand curve.
- 15  -COI* =  (w,S, +  PmMj)  (5)
where the values of Si and  Mi are calculated assuming that no vaccine is available.  In
Part III we compare COI with WTP for total prevention.
- 16-III. RESULTS
Empirical Analysis of Vaccine Demand
Description of Responses
Figure 4 and Table 9 show the number of vaccines respondents stated that they
would purchase at various prices.  Quantity purchased is clearly sensitive to price.  The
percent of households who say that they would buy no vaccines increases from 24
percent at a price of Birr 5 (0.80 USD) to 90 percent at a price of Birr 200 (32 USD) per
vaccine. The average quantity purchased also declines as price rises.
An important issue for policy is who within families would receive vaccines if
they were available.  Table 10 presents the percent of adults, teenagers and children who
would receive the vaccine by income category.  (The percentage of persons receiving the
vaccine in each case represents an average across sample prices.)  Two facts about the
table are striking. The first is that the percent of adults, teenagers and children receiving
the vaccine increases very slowly with income.  The second is that the percentage of
adults receiving the vaccine is, on average, higher than the percent of teenagers and
children.  This result, which is confirmed by our multivariate results below, suggests that
productivity concerns may motivate the allocation of vaccines among family members.
The data underlying Tables 9 and 10 can also be used to predict the number of
vaccines that would be purchased in a village of 200 households, assuming that these
households have the same characteristics as those in our sample.  Figure 5 plots the
number of vaccines purchased at each of our sample prices, and connects these points.
At a price of Birr 20 (3.2 USD) 400 persons (40 percent of the population of the village)
would receive the vaccine.  At a price of Birr 100 (16 USD), however, only 150 people
would receive the vaccine.  Since the revenue from selling 150 vaccines at Birr 100 per
vaccine is almost twice as great as the revenue from selling 400 vaccines at Birr 20 per
vaccine, there is clearly a trade-off between coverage and profit maximization, were a
vaccine to be sold as a private good.
Estimation of Household Demand Functions
To see how quantity demanded varies parametrically with price and with co-
variates, we estimate several forms of the demand function.  This also provides a test of
- 17 -the internal validity of our responses:  quantity demanded should increase with income
and education, holding other variables constant.  The discrete nature of the data suggests
using a count data model, such as the Poisson or Negative Binomial.  Below, we present
results for three models, the Poisson, the Negative Binomial, and the Truncated Poisson.
The last model imposes on the Poisson model the constraint that a household will never
purchase more than  n  vaccines.
The model described in Part II suggests that the number of vaccines purchased
should depend on vaccine -price,  household income and family size. It might also depend
on family composition, i.e., on the number of adults, children and teenagers in the family,
and on characteristics of the respondent--gender, age, marital status and education--which
may influence his taste for health-related goods. We measure education by whether the
respondent can read a newspaper.  Income, which enters the demand function in log
form, is made up of three components:  annual gross crop income, the annualized value
of livestock holdings and reported annual off-farm wages.  Since 28 percent of
observations on off-farm wages are missing, we replace missing values with zero and
then include a "missing wage'" dummy variable, equal to one if off-farm income is not
reported.
The demand for the vaccine should also depend on the incidence of malaria in the
area and on family members' susceptibilities to the disease. We proxy malaria incidence
by village altitude.  We proxy household susceptibility to malaria with a variable that
measures past experience with the disease.  Specifically, we sum the number of malaria
episodes that members of the household experienced during the last two years, weighting
each episode by the average age-specific cost of treatment.17 This is the household's
direct  COI.
Household size is measured by a series of dummy variables.  For example,
HHSIZE5 = 1 if the household has five members and = 0 otherwise.  This is because the
number of vaccines respondents say they will purchase does not increase linearly with
household size. Finally, we add a series of dummy variables to capture interviewer
effects.
17 The weights  are those  reported  in Table  5, based on all households  in the sample.
- 18-Table 11 presents parameter estimates for each of the three models. 18 The results
for the hypothetical vaccine models are generally consistent with economic theory.  The
number of vaccines that the respondent agrees to purchase decreases with price,
respondent age and altitude. Other things equal, older respondents might perceive
themselves to be at lower risk of contracting malaria than younger respondents.
Respondents at higher altitudes, whose families are less exposed to the vector, should
have a lower demand for the vaccine.  Demand increases with income, susceptibility to
the disease and being married.  The income elasticity of demand, 0.4, suggests that the
vaccine is NOT viewed as a luxury good, a result that is consistent with the literature on
willingness to pay to avoid illness.'9 Price elasticity of demand ranges from -0.08 at a
price of Birr 5 (0.8 USD) to -0.64 at a price of Birr 40 (6.4 USD).
The results for gender and family composition deserve some discussion.  The
coefficients on Married and Female indicate that women who are single heads of
household have significantly lower demands for vaccines than single male heads of
household or married women.  It is also the case that, holding household size constant,
the demand for vaccines is lower the larger the number of children in the household.
This result makes sense from an economic perspective, since children contribute less to
the household economically than do adults. It is also consistent with respondents'
statements as to who in the family would receive a malaria vaccine.  The percent of
children and teenagers who would receive the vaccine is lower than the percent of adults
who receive the vaccine.
Model Selection
Parameter estimates for each of the three models, while similar, are not identical.
This raises the question:  Which of the three models in Table 1  1 is preferred?  Table 12
provides additional evidence by which to judge the models.  The log of the likelihood
function suggests that the Poisson model is inferior to models 2 and 3.  Indeed, a
likelihood ratio test rejects the null hypothesis that the data follow a Poisson distribution
(Model 1).
18  Coefficients  of the household  size dummy  variables  and  the interviewer  dummy  variables  are reported  in
Appendix  II.
19 The income  elasticity  of willingness  to pay  to avoid illness,  a related,  but different  concept  from
elasticity  of demand,  is typically  between  0.3 and 0.6 (Loehman  and De, 1982;  Alberini  et al., 1997).
- 19  -The two remaining models, the Negative Binomial and the Truncated Poisson,
both under-predict the percent of households buying no vaccines and over-predict the
percent buying one or two.  The Negative Binomial model, however, predicts that
households buy more vaccines than family members in 6 percent of the cases, whereas
the Truncated Poisson model (by construction) never makes this error.  This, together
w1th  the fact that the Truncated Poisson model produces the largest number of
statistically significant coefficients, suggests that it is the preferred model.
As ani  additional test of the reasonableness of our results, we use the Truncated
Poisson model to predict the amount that each household would spend on vaccines, at
each price.  The mean and median values of this amount, expressed as a percent of
household income, are shown in Figure 6. Regardless of price, mean household
expenditure (expressed as a percent of income) is never more than 4 percent.  Median
household expenditure on the vaccine (as a percent of income) is never greater than 1.5
percent.
WYTP  to Pay  for  Prevention
Table 13 shows the implications of each of the three models for household WTP
for total prevention.  Calculated as the area under the household's  demand curve between
0 and  n  vaccines, annual household WTP is, on average Birr 229 (36 USD) (using the
Truncated Poisson model), with a median value of Birr 158 (25 USD).  Figure 7 shows
the distribution of WTP across households.  In the next section, we compare WTP with
the costs of illness.
Comparison of Willingness to Pay and Cost of Illness
In this section, we compare the private costs of illness for households in our
sample with WTP for prevention.  We begin by noting that there is a difference between
the Cost of Illness, as the term is used in the medical literature, and the COI in equation
(5) above. The traditional Cost of Illness does not value lost leisure time; moreover, it is
an ex post concept.  That is, it is computed by adding up actual expenditures and valuing
actual time lost due to illness that has occurred in the past.  COI* in equation (5) includes
the value of lost leisure time.  Furthermore, since the purchase of vaccines would prevent
,future illness, COI* should represent expectedfuture illness costs.
-20 -How much COI and COI* differ in practice depends (1) on the value attached to
leisure time and (2) on the way in which households form their expectations.  If the value
of leisure time is zero, and households assume that the future will be exactly like the past,
then the two concepts are identical.  In what follows we assume that households attach a
value of zero to their children's leisure time.  In the case of adults, the number of leisure
days lost to malaria is sufficiently small that we treat all time lost due to illness as
productive time lost.  We do, however, consider two ways in which households might
form their expectations about future illness costs.  Method one is to assume that their
family's future illness costs will equal the costs they actually incurred last year, i.e., that
COPI = COI, as calculated in Table 8.  Method two is to assume that families look
beyond their own experience and calculate their chances of contracting malaria using the
relative frequency of the disease in the population and using average illness costs (Table
14).
Expected COI Based on Average Sample Experience
Our second method of calculating the expected COI assumes that the chance that
an adult contracts malaria over the coming year equals the relative frequency of malaria
among adults in our sample.  A similar assumption is made for teenagers and children.
To compute the cost of an episode, we use the average per episode cost, as reported in
Table 7, based on all households.  The resulting average annual household COI must be
the same as the actual average COI shown in Table 8; however, COI figures for
individual families will differ under the two approaches.
Table 15 shows the ratio of WTP for malaria prevention to the COI, computed
under the assumption that adult productivity equals 0.75 of the daily wage for unskilled
labor. This ratio was computed for each household in the sample, using WTP estimates
from each of the three models in Table 13. The ratios were then averaged over all
households.  The results are quite similar for each of the three models, suggesting that
WTP for total prevention of malaria is about 3 times as great as the cost of illness.  This
result is quite similar to results obtained in industrialized countries when WTP to avoid
illness is compared with the conventional COI (Berger et al., 1987). It also has important
policy implications.  In evaluating the benefits of donor programs to control malaria, the
use of conventional COI figures, computed as in Part II, are likely to significantly
understate the benefits of such programs.
-21  -Household Demand for Bednets
Insecticide-treated bednets have helped to reduce the incidence of vector-borne
illness, as well as all-cause child mortality in various parts of Africa (Binka et al., 1997).
At the time of our study, however, impregnated bednets were essentially unknown to
households in Tigray as a method of treating malaria. 20 In the six villages in which we
administered the bednet scenario, our goal was to acquaint households with the use of an
insecticide-treated net and then to ask the respondent how many nets he would purchase
for his family at the price offered.
Table 16 and Figure 8 show the number of bednets households said that they would
purchase at each price.  Quantity demanded is clearly sensitive to price: the percent of
households who declined to purchase nets increases from 19 percent at a price of Birr 8
(1.3 USD) to 63 percent at a price of Birr 100 (16 USD).  The percentage of families who
said they would buy two or more nets also declines monotonically as price rises.  A rise
in price from Birr 8 to Birr 20 (3.2 USD) and from Birr 20 to Birr 40 (6.4 USD),
however, increases the percentage of families purchasing one net. Families who would
buy two nets at a lower price buy only one net as the price rises.
At each income level, the percentage of adults, teenagers and children covered by
bednets is much higher than the percent of each age group receiving vaccines  (see Table
16). This reflects, in part, the lower household cost of bednets, as well as fact that the
number of persons using a single net is flexible. Unlike vaccines, however, there is no
preference for allocating bednets to adults rather than to children.  Averaging across
sample prices, 53 percent of adults and teenagers and 61 percent of children would sleep
under bednets.
One reason for analyzing bednet demand is to predict the number of households
who would purchase bednets at various prices. For example, Table 16 can be used to
predict the fraction of households who would buy a bednet at a price that would permit
cost recovery.  It can also be used to determine what price would induce a desired
fraction of households to purchase nets.  Figure 9 illustrates the number of bednets that
would be purchased in a village of 200 households, assuming that these households have
20 In response to the question "What are the best ways to avoid getting malaria?" only 4 respondents
mentioned  sleeping  under a bednet  (either  unimpregnated  or impregnated).
- 22 -the same characteristics as those in our sample. At a price of Birr 40 (6.4 USD) per net,
for example, 166 nets would be purchased.  Calculating the number of people in the
village who would be covered at this price requires an assumption about the number of
people who sleep under a net.  If this is two, then one-third of the population of the
village would sleep under insecticide-treated nets at a price of Birr 40 (6.4 USD) per net.
Estimation of Household Demand Functions for Bednets
To estimate household demand functions for bednets we used models similar to
those used for the hypothetical vaccine. In terms of the theoretical model of Part II,
bednets are similar to vaccines.  Both goods can prevent illness, although they do so in
different ways.  Bednets do not offer complete protection against malaria; however, they
can reduce the inconvenience of insect bites, and can protect against other vector-borne
diseases.  We would therefore expect the number of bednets purchased to depend on the
same factors as influence the demand for the hypothetical vaccine.  Count data models
are also appropriate in this case since households buy a non-negative integer quantity of
bednets.
Table 17 presents estimates of Poisson, Negative Binomial and Truncated Poisson
models of the demand for bednets.  The explanatory variables are identical to those in the
vaccine models.  Fewer explanatory variables are, however, significant in the case of
bednets.  Indeed, the only variables whose coefficients are significantly different from
zero are price, income and age of the respondent.  Price is strongly significant in all three
models, with a coefficient that is similar in magnitude to the coefficient of price in the
vaccine models.  Income is marginally significant in the Poisson and Negative Binomial
models, as is respondent age. The income elasticity of demand for bednets is, however,
much lower than for vaccines:  a 10 percent increase in income increases the demand for
bednets by only 1 percent.  As in the case of vaccine, older respondents have lower
demand than younger respondents do. 21
The lack of significance of so many explanatory variables in the bednet models is
due in part to the smaller sample of households receiving the bednet scenario (279
households) v. the vaccine scenario (569 households).  We felt it more important to
21 The lack of significance  of the children  and  teenager  variables  mirrors  respondents'  answers  to a
question  asking  who would  use the bednets. The percent  of children  who would  receive  bednets  is not
- 23 -characterize the value of preventing malaria altogether, and therefore partitioned our
sample to ensure accurate estimates of vaccine demand.  Nevertheless, we believe Table
17 indicates that we probably have accurate estimates of the impact of price on the
purchase of bednets, which is most likely the variable of greatest policy significance.
Table 18 compares the performnance  of the three models in predicting within-
sample behavior.  A likelihood ratio test fails to reject the null hypothesis that the data
follow a Poisson distribution.  Since the Poisson model is a special case of the Negative
Binomial model and the Truncated Poisson model, it is not surprising that the three
models produce similar results.  All models over-predict the number of households
purchasing zero bednets or one bednet and underpredict the number of households
purchasing two or more bednets. This suggests that, for purposes of predicting bednet
purchases, it is better to rely on the raw data in Table 16.
Willingness to Pay for Bednets
Our estimates of bednet demand can also be used, as above, to compute the
household's total willingness to pay for a given number of nets.  To illustrate, suppose
that a donor were to provide enough bednets to protect all persons in a village.  What are
the economic benefits of such a program?  The value to a household of owning  x nets
(its total WTP for the nets) is the area under its demand curve between 0 and  x  nets.
Thus, the value of the program would be the sum of each household's total WTP for the
nets it received.  Assuming that each household received  n/2  nets, mean and median
household WTP for bednets are given Table 19.22
The numbers in Table 19 are considerably lower than those in Table 13. Although
bednets are a durable good, they provide only partial protection against malaria.
Moreover, they require some effort to use.  This helps to explain the fact that (using the
preferred model in each case) median WTP for bednets is 72 percent of median WTP for
vaccines.  On the other hand, a bednet would probably provide protection against
infection for 3 to 4 years if the insecticide were reapplied periodically, while the
hypothetical vaccine was assumed to last for only one year.
significantly  different  from  the percent  of adults  who would  receive  bednets.
22 When  not an integer,  n/2 was rounded  down  to the nearest  integer.
- 24 -IV. CONCLUSIONS
The purpose of this report is to estimate the value households place on preventing
malaria in Tigray, Ethiopia. Using the area under the household's  demand function for
vaccines to estimate this value, we find it to be about 36 USD per household per year-
about 15 percent of imputed annual household income.  This is, on average, about two to
three times the expected annual economic losses (medical costs plus productivity losses)
per household from the disease.
Two points about this result deserve emphasis.  First, it represents the private value
to households of eliminating the disease. This is likely to be smaller than the social value
of preventing malaria, which includes the costs of medical subsidies, community
spraying and other government-sponsored programs.  Second, this number represents the
household's maximum willingness to pay for prevention.  It is NOT the amount that
would be obtained by selling malaria vaccines to all members of the family, unless the
vaccines were sold by a price-discriminating monopolist.  This latter point has important
implications for cost recovery of malaria prevention schemes.
If a malaria vaccine were available, and if people in Tigray behaved as they told us
they would in this survey, revenues from the sale of vaccines would be maximized at a
price of 10 USD per vaccine. At this price, however, 75 percent of households would
purchase no vaccines.  This implies a steep trade-off between profit-maximization and
population coverage.  Our bednet results carry similar implications.  Figure 8 suggests
that, at a price that might permit cost recovery (6 USD per bednet), only one-third of the
population of a 200-person village would sleep under bednets.
What causes this apparent contradiction in results is the shape of the demand curves
for bednets and vaccines.  Both are very steep-implying  that, as the price of each good
falls, the number purchased increases, but gradually.  This makes it possible for
households' WTP for n  vaccines to be large (15 percent of income) even though the
percent of income spent on vaccines, which reflects the number actually purchased, is
small (never more than 4 percent of income).  The policy implications of this result are
that, while the benefits from allocating resources to bednets or malaria vaccines are large,
-25 -it will be difficult  for either  good to achieve  significant  market penetration  unless  the
price is subsidized.
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- 28 -Table 1. Number of Households Receiving Each Version of Questionnaire (n; column
percent)
Hypothetical Vaccine Scenario  Bednet Scenario
Price (Birr)  Sample Size  Price (Birr)  Sample Size
5  117 (21%)  8  58 (21%/)
20  120 (21%o)  20  59 (21%)
40  117 (21  %)  40  54 (19%o)
100  118 (21%)  60  52 (19%)
200  97 (17  %)  100  56 (20%)
Total  569 (100%)  Total  279 (I0OM)
Table 2. Mean Value of Livestock for Households Who Own Livestock (Birr*)
Type of Livestock  N  Mean  Price  Value
Sheep  219  5  80  402
Oxen  594  2  875  1632
Goats  395  7  60  437
Chickens  674  6  7  41
Cattle  475  2  200  495
Donkey  291  1  300  412
*1 USD = Birr 6.3
- 29 -Table 3. Household Demographic Characteristics
Variable  Obs  Mean  Median
Household size  848  5  5
Number of adults  848  2  2
Number of teenagers  848  1  0
Number of children  848  2  2
Respondent gender (0=male & 1=female)  848  57%  1
Respondent age  847  42  40
Respondent can read newspaper easily  848  13%  0
Table 4. Household Malaria Incidence (in last 2 years unless otherwise specified)
Variable  N  Mean  Median
[Trimmed
Mean]*
Respondent had malaria in lifetime  848  78%  1
Respondent had malaria  848  58%  1
Households where other adults had malaria  842  53%  1
Households where children/teens had malaria  845  49%  0
Households where somebody died of malaria  803  7%  0
(lifetime)
No. times the respondent had malaria  656  2.7 [1.8]  2
No. of other adults who have had malaria  451  1.5  1
No. children/teenagers who have had malaria  415  2.0  2
*Trimmed means are obtained by setting all values greater than the ninety-fifth percentile
equal to the ninety-fifth percentile.
- 30-Table 5. Elements of Direct Cost of Illness per Episode, Sample Averages by Age Group
Variable  All Households  Households Who Ever Had Malaria
Confirmed by a Medical Test
Adults  Birr  USD  Birr  USD
Treatment Costs  8  1.3  10  1.6
Costs of Medicine  1.423  0.2  1.624  0.3
Transportation  0.625,26  0.1  0.827  0.1
Costs
Direct COI  10  1.6  13  2.0
Teenagers  _  _
Treatment Costs  5  0.8  10  1.5
Costs of Medicine  1.428  0.2  129  0.2
Transportation  0.230  31  0.04  0.832  0.1
Costs
Direct COI  7  1.1  1 1  1.8
Children
Treatment Costs  4  0.6  5  0.8
Costs of Medicine  1.033  0.2  I.134  0.2
Transportation  0.1777  j  0.02  0.337  0.05
Costs
Direct COI  5  0.8  7  1.0
* Rounding errors account for direct COI estimates that are not sums of its three
components.
23 The average  of cost of medicine  for those that paid is Birr 7.
24 The average  of cost of medicine  for those that paid is Birr 5.
25 Values  that are greater  than  the ninety-fifth  percentile  are replaced  with the value of the ninety-
fifth percentile  (Birr 10).
26 The average  transportation  costs over only households  that incurred  travel costs are Birr 7.
27 The average  transportation  costs over only households  that incurred  travel costs are Birr 6.
28 The average  of cost of medicine  for those that paid is Birr 7.
29 The average  of cost of medicine  for those that paid is Birr 8.
30 Values  that are greater  than the ninety-fifth  percentile  are replaced  with the value of the ninety-
fifth percentile  (Birr 6).
31 The average  transportation  costs  over only  households  that incurred  travel costs are Birr 5.
32 The average  transportation  costs over only households  that incurred  travel costs are Birr 6.
33 The average  of cost of medicine  for those that paid is Birr 7.
34 The average  of cost of medicine  for those that paid is Birr 6.
35 Values  that are greater  than  the ninety-fifth  percentile  are replaced  with the value of the ninety-
fifth percentile  (Birr 6).
36 The average  transportation  costs over only  households  that incurred  travel costs are Birr 5.
37 The average  transportation  costs  over only households  that incurred  travel costs  are Birr 4.
- 31 -Table 6. Productivity Losses Per Malaria Episode, by Age Group (Average Number of
Days)
Age Group  All Households  Households Who Ever
Had Malaria Confirmed
by a Medical Test
Adult  Teens  Children  Adult  Teens  Children
Duration of Illness  22  26  16  19  28  11
Patient's Lost Work Days  18  18  2  14  19  2
Gains in Household  14  10  1  12  10  1
Productivity Due to Intra-
household Labor Substitution
Losses in Household  6  5  1  3  2  1
Productivity Because
Substitute Laborer Does Not
Do Their Own Work
Days Lost Due To Intra-  11  13  11  9  6  7
household Caretaking
Net Number of Work Days  21  26  12*  15*  17  8*
Lost Due to an Episode of
Malaria
*These columns do not add up because of rounding errors.
Table 7. Average Cost of Illness Per Episode, Using High and Low Productivity
Assumptions
Age  All Households  Households Who Ever Had
Group  Malaria Confirmed by a Medical
_  _  ~~~~~Test
1997 Birr  1997 USD  1997 Birr  1997 USD
Adults  46-151  7-24  38-113  6-18
Teenagers  41-145  7-23  32-94  5-15
Children  23-78  4-12  19-55  3-9
- 32 -Table 8.  Average Annual Cost of Illness Per Household, Using Actual Illness (n=848)
Daily Productivity  1997 Birr  1997 USD
(Percent of Daily  Mean [std. dev.]  Mean [std.  dev.]
Wage)
100  196 [150]  31 [24]
75  103 [801  16 [131
50  58 [45]  9 /7]
Table 9. Number of Hypothetical Vaccines Purchased by Price
0 vaccines  1-3 vaccines  4-6 vaccines  >=7 vaccines
Price 5  24%  35%  33%  8%
Price 20  48%  25%  22%  6%
Price 40  68%  21%  10%  2%
Price 100  81%  10%  6%  3%
Price 200  90%  6%  4%  0%
Table 10. Coverage with Vaccines by Income Group and Demographic Category
Annual Income  Adults  Teenagers  Children
Low (< Birr 800)  27%  21%  23%
N  409  131  322
Middle  28%  25%  31%
N  448  141  395
High (> Birr 1,550)  29%  31%  24%
N  470  187  394
- 33 -Table  11.  Parameter Estimates for Hypothetical Vaccine Models (n =  569)
Variable  Poisson  Negative  Truncated
Binomial  Poisson
Price  -0.012  -0.014**  -0.016*'
(Birr)  0.001  0.001  0.001
Log household income  0.209**  0.288  0.402**
(thousands  of Birr)  0.056  0.108  0.052
Missing wage  -0.002  -0.014  0.059
(1 if no wage)  0.122  0.211  0.106
Number of teenagers  0.023  -0.033  0.001
(number)  0.067  0.133  0.058
Number of children  -0.098*  -0.206*  -0.222**
(number)  0.058  0.112  0.047
Household dir. cost of illness  0.011  0.013  0.016**
(Birr)  0.003  0.005  0.002
Married  0.297**  0.402  0.475**
(1 if Married)  0.140  0.261  0.135
Gender  -0.150*  -0.265*  -0.281
(1 if female)  0.083  0.159  0.072
Read  0.196**  0.313*  0.291  **
(1 if read easily)  0.086  0.167  0.072
Age  -0.011  **  -0.016  -0.021
(years)  0.003  0.006  0.003
Altitude  -0.062**  -0.085*  -0.082
(hundreds  of meters)  0.026  0.047  0.021
Intercept  0.590  0.839  2.137**
0.610  1.071  0.725
Lnca  0.058
0.148
Notes:  Dichotomous  variables  for household  size and enumerators  are not included  in Table. Standard
errors  in small  font.
Significant  at the 5% level
Significant  at the 10%  level
- 34 -Table 12. Goodness of Fit Criteria for Hypothetical Vaccine Model
Actual  Poisson  Negative  Truncated
Binomial  Poisson
Log Likelihood  N/A  -856.26  -764.05  -768.71
Mean YJX  1.45  1.45  1.63  1.06
Variance of YlX  4.74  2.34  5.28  1.05
Y > household size  0%  2%  6%  0%
Frequency
0  61%  52%  56%  59%
1  6%  23%  19%/o  24%
2  7%  12%  9%  10%
3  7%  5%  5%  6%
4  7%  6%  3%  1%
5  6%  2%  2%  0%
6 or more  7%  2%  6%  0%
Table 13. Willingness to Pay for Hypothetical Vaccine (n = 569)
Poisson  Negative  Truncated
Binomial  Poisson
Willingness to pay
Mean  202  205  229
Median  163  139  158
Standard Deviation  147  188  208
Minimum  7  6  7
Maximum  883  1046  1117
Table 14. Average Annual Cost of Illness Per Household Using Sample Illness
Frequencies to Predict Future Illness and Average Per Episode COI  (Entire Sample)
Daily Productivity  1997 Birr  1997 USD
(Percent of Daily  Mean [std. dev.]  Mean [std.  dev.J
Wage)
100  196 [183]  31 [29]
75  104 [97]  17 [15]
50  59 [55]  9 [9]
-35 -Table 15. Ratios of Three Estimates of WTP for Malaria Vaccine to Two estimates of
Expected Cost of Illness Per Household
Models Used to  Mean of Ratio of WTP to  Mean of Ratio of WTP to Ex
Estimate WTP  Actual Household COI (See  Ante Household COI (See
Table 8) [std. dev.]  Table 14) [std. dev.]
Truncated Poisson  3.10 [4.03]  2.32 [1.98]
Poisson  2.80 [3.33]  1.98 [1.37]
Negative Binomial  2.76 [3.58]  2.01 [1.71]
Table 16. Number of Bednets Purchased by Price
0 nets  1 net  2 nets  3 or more nets
Price 8  19%  21%  43%  17%
Price 20  22%  33%  32%  13%
Price 40  41%  37%  20%  2%
Price 60  52%  23%  19%  6%
Price 100  63%  25%  11%  2%
- 36 -Table 17. Parameter Estimates for Bednet Models (n = 279)
Variable  Poisson  Negative  Truncated
Binomial  Poisson
Price  -0.014*  -0.014*  -0.016's
(Birr)  0.002  0.002  0.003
Log household income  0.093*  0.093*  0.097
(thousands of Birr)  0.059  0.059  0.075
Missing wage  0.019  0.019  0.265
(I if nowage)  0.188  0.188  -0.132
Number of teenagers  0.116  0.117  .0.118
(number)  0.109  0.109  0.147
Number of children  0.044  0.044  0.032
(number)  0.099  0.099  0.142
Household dir. cost of illness  -0.005  -0.005  -0.006
(Birr)  0.005  0.005  0.006
Married  .0.045  0.045  0.022
(I if married)  0.195  0.195  0.271
Gender  0.012  0.012  0.009
(1 if female)  0.146  0.146  0.213
Read  0.022  0.022  -0.010
(1 if read easily)  0.160  0.160  0.224
Age  -0.010  -0.010*  -0.012
(years)  0.005  0.005  0.008
Altitude  0.067  0.067  0.082
(hundreds of meters)  0.038  0.038  0.049
Intercept  -0.541  -0.541  0.461
0.844  0.846  1.116
Lncx  -17.323
Notes: Dichotomous variables for household size and enumerators are not included in Table. Standard
errors in small font.
Significant at the 5% level
Significant at the 10% level
- 37 -Table 18. Goodness of Fit Criteria for Bednets
Actual  Poisson  Negative  Truncated
Binomial  Poisson
Log Likelihood  N/A  -322.30  -322.30  -311.75
Mean YJX  1.07  1.07  1.07  1.09
Variance of YIX  1.63  0.56  0.56  0.57
Y>(household size)/2  0%  2%  2%  0%
Frequency
0  39%  54%  54%  52%
1  28%  37%  37%  38%
2  25%  8%  8%  8%
3  6%  1%  1%  1%
4  0%  0%  0%  0%
5  0%  0%  0%  0%
6 or more  1%  0%  0%  0%
Table 19. Willingness to Pay for Bednets (n = 279)
Poisson  Negative  Truncated
Binomial  Poisson
Willingness to pay
Mean  123  123  138
Median  113  113  122
Standard Deviation  68  68  84
minimum  18  18  6
Maximum  465  465  597
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- 43 -APPENDIX I: Household Questionnaire
Name of Enumerator:  Version No.:
Date:  Questionnaire No.:
Time Start:  Village Name:
Introduction
[Enumerator: Read the following introductory statement.] My name is  and I am working  on a
survey about health issues in Tigray for the World Health Organization. We are interested in learning how
people feel about different health problems. This research will help the government and donor agencies
select the health policies for Tigray that people most want. We are interviewing many different
comnmunities  and households in Tigray. The interview will be completely confidential, and if at any time
you wish to stop the interview or not answer a specific question, this is entirely up to you. The interview
will take less than one hour.
L..  Would you be willing to be interviewed?
(0) No (STOP THE INTERVIEW)
(1) Yes
2.. Are you the head of the household or the spouse of the head of the household?
(0)  No (STOP THE INTERVIEW)
(1) Yes
[Note: Only the head of household, or his/her spouse should be interviewed.]
3. [Enumerator: What is the gender  of the respondent?J
(0) Male
(1) Female
4.. How many people live in this household, including yourself?
No. of individuals
5.. How many adults (greater than or equal than 18 years) live here?
No. of adults
6. How many teenagers (12-17 years) live here?
No. of teenagers
7. How many children I I  years or younger live here?
_  No. of children
(Enumerator: Add the responses to questions 5, 6, and 7 and check that the sum is the same as the
response to question 4)
______  Total of questions 5, 6, and 7
Social Priorities
8. 1 am going to read a list of projects that the government could implement if it received more foreign aid.
Which one would you most prefer the government to spend money on? [Enumerator: Place tick next to the
first choice. Mark only one response!
-(I)  Increase supply of drugs for health clinic
____  (2) Increase the supply of supplies, books and equipment for the schools.
_  (3) Ensure an adequate, safe drinking water supply for each household in Tigray.
____  (4) Increase malaria control programs.
(5) Improve credit programs.
- 45 -(6) Provide irrigation systems to water crops.
_  (-98) Don't know/Not sure
Health history
3-a . Health status
9.
How would you describe your health compared to the health of other people your age in this village?
_  (2)Much better
_(l)Better
_(0)  About the same
(-1) Worse
=  (-2) Much worse
(-98)Don't know/Not sure
10. Do you have a chronic illness (an illness that lasts a long time and/or comes back frequently)?
(0) No
(1) Yes
_____  (-98) Don't know/Not sure
I1. What do you think is the most important disease in your village? [Enumerator: Do not read list of
responses. Recordfirst  response only. Mark only one.]
(1) Malaria
______  (2) Tuberculosis






(-95): Other (please specify)
(-98) Don't know/Not Sure
12.Do you have free papers for medical care?
(0) No
(1) Yes
13. Do you have to pay for examination fees if you see a health worker at the nearest health clinic?
(0) No (GO TO QUESTION 15)
______(1) Yes
(-98) Don't know
14. How much would you have to pay in examination fees to see a health worker at the nearest health
clinic?
Birr
_  (-98) Don't know/Not Sure
15. Do you have to pay for medicine when you need it?
(0) No (GO TO SECTION 3-B)
(1) Yes
(-98) Don't know
16. How much would you have to pay for medicine if you need it?
Birr
_(-98)  Don't know/Not Sure
- 46  -3-b. Respondent  malaria  knowledge
Now I would like to ask you what you know about the sickness  known as malaria?
[Enumerator: In this section, do not read the responses. Let the respondent answer the question. If the
response is i  the list below, place a tick mark next to the response. If the response is not in the list below,
write the response in "Other"]
17. Do you know what malaria is?
(0) No (GO TO SECTION 3-E)
(1) Yes
18. How is malaria transmitted? [Enumerator: Do not read list. Place tick marks next to all that apply.]
a. _  Mosquitos
b.  Lack of sanitation
c.  _Impure  water
d.  _Wet  places
e.  -Other:
f.  Don't know/Not sure
19.  What are the symptoms of malaria? [Enumerator: Do not read list. Place tick marks next to all that
apply.]
a. _  Fever
b.  Shivering
c.  Convulsions
d. _  Headache
e.  Backache
f. _  Anemia
g. _  Stomachache
h. _  Vomiting
i. _  Diarrhea
j. __Joint  pain
k.  _Loss  of appetite
1.  _  Other:
m.  Don't know/Not sure
20. Is malaria more serious for adults or for children?
_(I)  Adults
_(2)  Children
(3) Equally serious for adults and children
_(4)  Not serious for adults or children
(-98) Don't know/Not sure
21. If someone is sick with malaria, what are the best ways to cure this person? [Enumerator: Do not read
list. Place tick marks next to all that apply.]
a.  No treatment is necessary
b.  Taking chloroquine




g._  Changing one's diet
h.  Cleaning house, environment, or body
i.  Religious healing: Holy water, debtera
j._  Herbal medicines
k.  Other:
1.  _Don't  know/Not sure
- 47  -22.  What are the best ways to avoid getting malaria? [Enumerator: Do not read list. Place tick marks next
to all that apply.]
a.  There is no way to prevent malaria
b. _  Cleaning the house or environment, including draining wet areas
c. _  Sleeping under a bednet
d. _  Taking chloroquine
e. _  Taking other medicine (please specify)__
f.  Eating a special diet(includes avoiding certain foods)
g. ____Burning leaves, dung, and other materials
h.  Spraying insecticides
i. _  Othert
j.  _Don't  know/Not sure
3-c. Respondent  Malaria  History
Now I would  like to talk with you about  malaria.
23. Have you ever had malaria?
(0) No  (GO TO SECTION 3-D)
_____  (1)Yes
(2)Had fever, but doesn't k now if had malaria  (GO TO SECTION D)
24. Did you get malaria in this village or somewhere else?
____  (0) In this village
(1) Somewhere else
(-98) Don't know/Not sure
25. How did you know that you had malaria? (Enumerator: Mark first response only.)
(1) Medical tests
(2)Community health worker told me
(3)Traditional healer told me
(4)1  recognized the symptoms myself as being those of malaria
_  (5) A family member told me that I had malaria
_  (-98)Don't know / Don't remember
26. How many times have you had malaria over the past two years?
No. of times
[Enumerator: If zero, GO TO SECTION 3-DI
Now I want to talk with you about that most recent episode.
27. When was the last time you had malaria?
(I) Kiremti (June-September)
(2) Kawie (October -November/December)
(3) Hagai (December - March)
(4) Belgi/Asmera (April - May)
a.  198_  Year (Ethiopian calendar)
28. How many days were you sick with malaria?
_____No. of days
(-98) Don't know
29. Did you stop working?
(0) No (GO TO QUESTION 38)
(I) Yes
-48 -30. How many days did you miss work?
_____No. of days
(-98) Don't know
31. Did someone do your work for you?
(0) No (GO TO QUESTION 35)
(l)Yes
(-98) Don't know/Not Sure (GO TO QUESTION 35)
32. Was this person an adult, teenager, or a child?
(1) Adult (equal to or greater than 18 years old)
_______  (2)Teenager (11-17 years old)
(3) Child (less than or equal to 10  years old)
(-98) Don't know/Not Sure
33. Did the person who worked in your place cut back on their own duties?
(0) No (GO TO QUESTION 35)
(I)Yes
(-98) Don't know/Not Sure
34.How many days did this person cut back on their own duties?
No. of days
(-98) Don't know/Not Sure
35. Were you so sick that someone had to cut back on  their own duties for one or more days just to care
for you?
(0) No (GO TO QUESTION 38)
(I)Yes
(-98) Don't know/Not Sure
36. Was this person an adult, teenager, or a child?
(1) Adult (equal to or greater than 18 years old)
(2) Teenager (11-17 years old)
(3) Child (less than or equal to 10  years old)
(-98) Don't know/Not Sure (Go to question 38)
37. How many days did this person cut back on  their own duties just to care for you?
______  No. of days
(-98)  Don't know/Not Sure
38. Did you seek treatment for malaria?
(0) No (GO TO SECTION 3-D)
(1) Yes
39. What treatment did you first seek? [Enumerator: Do not read list. Mark  first  response only.] (If the
respondent says  "doctor,  " ask where the doctor is  found  For example, in the clinic or hospital)
(I) Traditional medicines: holy water, debtera, prayer, habamesh medicine, herbal medicines
______  (2) Went to the clinic
(3) Went to the pharmacy only
(4) Went to the Community health worker
(5) Went to the hospital
(6) Clean the environment (GO TO SECTION 3D)
(-95) Other (specify:)  (GO TO SECTION 3-D)
- 49  -40. How  much did it cost to receive  this  treatnent not including  the cost of transportation?  (Ifpayment  was
made in other goods besides Birr, please specify the type of good, the unit it is measured in, and the
amount they used in payment.)
a.  Birr
_(-98)  Don't  know/Not  Sure (GO  TO QUESTION  42)
If payment  is in kind
b.  .type of good
c.  unit
d.  number  of units
41. Does  this  cost include  the cost  of medicine?
(O)  No
_________(l)Yes
(-98) Don't know/Not Sure




_  (3) Fansidar
_  (4)Quinine
_  _  (5) Herbal treament (specify:)
______  (-95) Other (specify):
____  (-98) Don't know
43. What form of tranportation did you take? (Enumerator: Choose all that apply.)
____  (1) Walk (GO TO QUESTION 45)
(2) Truck/Bus




44. How  much did transportation  cost, in money  or other  things?  (Ifpayment  was made in other  goods
besides Birr, please specify the type of good, the unit it is measured in, and the amount they used in
payment.)
a. _  Birr (GO TO  QUESTION  45)
(-98) Don't  know/Not  Sure
If payment  in kind
b.  payment  in  kind:  type of good
c.  unit
d.  number  of units
45. How many hours did you  travel  one way to receive  this treatment?
No. of hours
(-98) Don't know
46. Were  you cured?
(O)  No
(1) Yes
3d. Malaria incidence and household malaria history
(Enumerator: If at any point in this section, the respondent says that a family member has died of malaria,
skip to question  )
- 50  -Now I'd like to ask you about other adults in your household, besides yourself, and their experience with
malaria.
47. Have any other adults is this household had malaria over the past two years?
____(l)  Yes
(0) No  (GO TO QUESTION 50)
(-98) Don't know/not sure (GO TO QUESTION 50)
(-97) There aren't other adults in this household (GO TO QUESTION 50)
48.  In total, how many other adults had malaria over the past two years?
No. of adults
(-98) Don't know/not sure
(-99) Did not answer
49. Did these adults get malaria in this village or somewhere else?
_  (0) Somewhere else
(1) In this village_(-98)  Don't know
50. Have any of the teenagers or children in this household had malaria over the past two years?
(I) Yes
(0) No  (GO TO SECTION 3E)
(-98) Don't know/not sure (GO TO SECTION 3E)
(-97) There are no teenagers or children (GO TO SECTION 3E)
51. In total, how many teenagers and children in this household had malaria over the past two years?
_____No. of teenagers and children
_ (-98) Don't know/not sure
_____  (-99)  Did not answer
Now I am going to ask you about the last time one of your children had malaria.
52. When was the last time a teenager or child in this household had malaria? [Enumerator: If more than
one teenager or child had malaria at the same time, please think of the youngest of the teenagers or
children and answer the following questions about the last time he or she had malaria]
(1) Kiremti (June-September)
(2) Kawie (October -November/December)
(3) Hagai (December - March)
(4) Belgi/Asmera (April - May)
a. 198_  198_  Year (Ethiopian calendar)
53. What is the gender of this teenager or child?
(0) Male
_____  (1) Female
54. How old was the teenager or child?
years
55. Did this teenager or child get malaria in this village or somewhere else?
______  (0) In this village
(1) Somewhere else
(-98) Don't;know/Not sure
56. How many days did the malaria last?
____No.  of days
_____  (-98) Don't know/not sure
- 51 -57.'Did  he/she stop performing his/her normal duties?
(0) No (GO TO QUESTION 63)
(1) Yes
58. How many days did he/she miss his/her normal duties?
No. of days
59. Did someone else take over these duties?
____  (0) No (GO TO QUESTION 63)
(I) Yes
(-98) Don't know/Not Sure (GO TO QUESTION 63)
60. Was this person an adult, teenager, or a child?
(1) Adult (equal to or greater  than 18 years old)
(2) Teenager (1 1-17 years old)
(3) Child (less than or equal to 10 years old)
(-98) Don't know/Not Sure
61. Did the person who took over these duties miss their own work?
(0) No
(1)  Yes
_  _  (-98) Don't know/Not Sure
62. How many days did this person cut back on their own duties?
______  No. of days
_____  (-98) Don't know/Not Sure
63. Did someone miss work just to care for the sick child/teenager?
____  (0) No (GO TO QUESTION 66)
_____(1)  Yes
(-98) Don't know/Not Sure
64. Was this person an adult, teenager, or a child?
(1) Adult (equal to or greater than 18 years old)
(2) Teenager (11-17 years old)
(3) Child (less than or equal to 10  years old)
(-98) Don't know/Not Sure
65. How many days did this person miss work just to care for the sick teenager or child?
No. of days
66.  Did you seek treatment for the sick teenager or child?
____  (0) No (GO TO SECTION 3E)
_____  (1)  Yes
67. What treatment did you seek first? [Enumerator: Do not read list. Mark first response only.]
(1) Traditional medicines: holy water, debtera, prayer, habamesh medicine, herbal medinicines
(2) Went to the clinic
(3) Went to the pharmacy only
(4) Went to the Community health worker
(5) Went to the hospital
(6) Clean the environment (GO TO SECTION 3E)
(-95) Other (specify:)  (GO TO SECTION 3E)
68.  How much did it cost to receive this treatment not including the cost of transportation? (Ifpayment
was made in other goods besides Birr, please specify the type of good, the unit it is measured in, and the
amount they used in payment.)
- 52 -a.  Birr
_  (-98)  Don't know (GO TO QUESTION 70)
If payment in kind
b.  -type  of good
c.  unit
d.  number of units
69. Does this cost include the cost of medicine?
(0) No
_____  (1)  Yes
(-98) Don't know/Not Sure






(5) Herbal treament (specify:)
(-95) Other (specify:)
_  (-98) Don't know
71. What form of transportation did you take? (Enumerator: Mark first response only.)
(I) Walk (GO TO QUESTION 73)
(2) TrucklBus
(3) Cart
_____  (4) Animal
______  (5) Stretcher
(6) Other:
72. In total, how much did transportation cost, in money or other things? (If payment was made in other
goods besides Birr, please specify the type of good, the unit it is measured in, and the amount they used in
payment.)
a. __Birr
_  (-98)  Don't know/Not Sure
If payment in kind
b.  -type  of good
c.  unit
d.  number of units
73. How many hours did you travel one way to receive this treatment?
_____  No. of hours
_____  (-98) Don't know
74.  Was the teenager or child cured?
_____  (0) No
(I) Yes (GO TO SECTION 3E)
(-98) Don't know
(Enumerator: If respondent provided the information to answer the next two questions, do not ask the
questions, but answer the questions using information that they already gave you. If they did not answer
these questions, then ask.)
75.  Has anyone in your family ever died of malaria?
_  (0) No (GO TO SECTION 3E)
- 53  -(1) Yes
_  (-98) Don't know (GO TO SECTION 3E)
76.
How was that person related to you?
(1) Parent
_______  (2) Brother or sister
(3) Spouse
(4) Child
(5)  Other: (please specify)
3e.  Avertive  behaviors
Do you normally do any of the following things to try to prevent malaria:
77. Do you normally take medicine before you get sick in order to prevent malaria?
(0) No
(1) Yes (GO TO QUESTION 79)
(-98) Don't know/Not sure (GO TO QUESTION 79)
78.  Why not? (Enumerator: Mark  first  response only.)
_  (1) Too expensive
(2) Too time consuming/inconvenient
_  (3) Not applicable to me
_  (4) Not aware of it
(5) Not available
_  (6) Malaria not a problem where I live
(7) Not effective
(-95))  Other: (please specify)
79. Do you normally spray your house to kill mosquitoes? (Enumerator: This does not include spraying
done by malaria control authorities.)
(0) No
_  (1) Yes (GO TO QUESTION 81)
(-98) Don't know/Not sure (GO TO QUESTION 81)
80. Why not? (Enumerator: Mark  first response only.)
(1) Too expensive
_  (2) Too time consuming/inconvenient
_ (3) Not applicable to me
_  (4) Not aware of it
(5) Not available
(6) Malaria not a problem where I live
(7) Not effective
_  (-95))  Other: (please specify)
81. Do you normally drain areas of water near your house to prevent mosquitoes from breeding?
(0) No
(1) Yes (GO TO QUESTION 83)
(-98)  Don't know/Not sure (GO TO QUESTION 83)
82. Why not? (Enumerator: Mark  first  response only.)
(1) Too expensive
=  (2) Too time consuming/inconvenient
(3) Not applicable to me
(4) Not aware of it
(5) Not available
- 54 -(6) Malaria not a problem where I live
(7) Not effective
(-95))  -Other: (please specify)
83. Do you normally burn dung or leaves to keep mosquitoes away?
(0) No
(1) Yes (GO TO QUESTION 85)
(-98) Don't know/Not sure (GO TO QUESTION 85)
84. Why not? (Enumerator: Mark  first response only.)
(1) Too expensive
(2) Too time consuming/inconvenient
(3) Not applicable to me
(4) Not aware of it
(5) Not available
(6) Malaria not a problem where I live
(7) Not effective
(-95))  Other: (please specify)
85. Has the govemment sprayed your house and community with insecticides to kill mosquitoes in the last two years?
(0) No
(I) Yes
(-98) Don't know/Not sure
86.  Does your community drain areas of standing water, including puddles, tree stumps, pots collecting
water, and swamps, in order to control mosquito populations? (Enumerator. This includes only spraying
done by Malaria Control.)
(0) No
- (1) Yes, my community drains these types of areas
Choice between Two Health Programs
Suppose that the government of Tigray is considering two programs to rehabilitate and improve the hospital and to fight the main
diseases here in Tigray.
Program A would save 100 lives in the next 12 months.
Program B would save [200/500/10001 lives in [2/5/101  years.
87. Assume the two programs cost the same but that there is money to implement only one of them. I would like to ask you which of
the two programs you would choose, or which of the two programs you think should be implemented in Tigray.
(0) Program A (GO TO QUESTION 88)
(1) Program B (GO TO QUESTION 89)
_  (-98) Don't know / Didn't understand / Don't want to answer (GO TO SECTION 6)
88.  Why did you choose program A? (Enumerator: Choose only one.)
_  (I) One should live day by day
(2) The future is uncertain
_  (3) The life I save may be my on (or my family is living now)
_  (4) Solve problems now
(5) Don't know
_  (6) Technology progress provides means to save people in the future
_  (-95)  Other  (please  specify)
(Enumerator: GO TO SECTION 6)
89. Why did you choose program B? (Enumerator: Choose only one.)
(1) Make the future better
(2) Future oriented program saves more lives
_  55  -(3) Other (Please specify)
(-98) Don't know
Socio-economic profile
Now I want to ask you some questions about your household
6a. Education
90.  How many years of education have you completed? (or, What is the highest level of education you
have completed?) (Enumerator: Choose all responses that apply.)
(0) No schooling (grade)
____  (1) 1  2  3  4  5  6  Primary school
_____  (2) 7  8  Middle school
____  (3)9  10  11  12 Secondary school
(4) University
_____  (5)  Literacy Training
_____  (6) Vocational School
(7) Church School
_  (-95) Other
(-98) Don't Know
91. Can you read a newspaper?
_____  (0) No
_  (I) Yes, but with difficulty
(2) Yes,  easily
92. Are you married?
_  (0) No (single-or divorced) (GO TO QUESTION 97)
_  (1) Yes
93. Is your spouse alive?
(0) No (GO TO QUESTION 97)
(1)  Yes
94.  How many years of education has your spouse completed? (or, What is the highest level of education
your spouse has completed?) (Enumerator: Choose all responses that apply.)
(0) No schooling
(grade)
(1) 1  2  3  4  5  6 Primary school
(2) 7  8 Middle school
(3) 9  10  11  12 Secondary school
(4) University





95. Can your spouse read a newspaper?
(0) No
_____  (1) Yes, but with difficulty
(2) Yes, easily
6b. Occupation
96. What is your spouse's primary occupation during the year?




_____  (4) Skilled labourer/tradesman - e.g. carpenter
_____  (5) Small Trader
_____  (6) Civil servant
(7)Soldier
(-95)  Other (specify type of work)
97. What is your primary occupation during the year?




(4) Skilled labourer/tradesman - e.g. carpenter
_____  (5) Small Trader
______  (6) Civil servant
______  (7)Soldier
(-95) Other (specify type of work)
6c. Housing
98. How many rooms does this respondent's dwelling unit have?
No. of rooms
99. ?How many buildings are there in this compound?
-No. of buildings
100. How many households live in this compound?
No. of households
101. Do you own or rent this house/flat?
____  (0) Rent (GO TO QUESTION 103)
(1) Own
102. If I want to sell a house like yours,  how much can I sell it for?
(Birr  (GO TO QUESTION 104)
(-98)  (Don't know  (GO TO QUESTION 104)
(-99)  (Refused to answer (GO TO QUESTION 104)
103. What is your monthly rent?
Birr
104.  [Enumerator: If this village does not have electricity, go to section 6D]
105. Does this house have electricity?
(0) No  (GO TO SECTION 6D)
(1) Yes
106. How much was your last household electric bill ?
Birr per month
(-98) Don't know
a.  (1) ((Electricity is included in rent)
107.  ( (IF THE ELECTRIC BILL IS SHARED),  What is your household's share of the electric bill?
Birr per month
- 57  -(-98) Don't know
6d.  Cooking
108. What is the main fuel you use for cooking? (Enumerator: Do not read list.  Tick only one response.)
____  (1) Dung
(2) Firewood
_  (3) Crop residue
_____  (4) Kerosene
(5) Charcoal
(6) Electricity  (-95)  Other (please specify)
6e. Credit market
109.  If you wanted to borrow 100 Birr from a local money lender for one month (not from a family
member), how easy  would this be?
(0) Quite easy to do
_____  (1) Possible, but not easy
(2) Impossible (GO TO QUESTION 111)
(-98) Not Sure (GO TO QUESTION 111)
110. How many Birr would you have to pay in addition after one month?
Birr (additional)
(-98) Not Sure
11  1. Have you done any of the following in the last year? (CHECK ALL THAT APPLY)
a.  deposited cash in a bank
b.  deposited cash with the REST credit scheme
c.  purchased livestock with the intention of selling them in the future for more money
d.  sent your children or other members of the household (including adults) to school or training
classes
e.  None
112.  Have you borrowed money from the following sources in the last year? (CHECK ALL THAT APPLY)
a.  Family/friends
b.  moneylender
c.  bank or credit institution
d.  None
Credit
113.  I want you to suppose that a private rural bank opened in [name of nearby town  1, and that this bank was willing
to take make loans. Suppose that the bank were willing to make you a loan of 100 Birr. You would be required to pay back
[150,200,350] Birr in [1,2,5] years, in order to pay back this loan. Under these loan conditions, and given your current situation, would
you want to borrow 100 Birr; or would you prefer not to borrow?
Yes, I would borrow 100 Birr now, and repay [100,200,350] Birr in [1,2,5] (GO TO QUESTION 114)
No, I would not borrow 100 Birr now (GO TO QUESTION 115)
_____  Don't know/Not sure (GO TO SECTION 6F)
114. If yes, why?
a.  Lower repayment than other sources
b.  I can't borrow from anywhere else
c. _  Other (please specify):_
(GO TO SECTION 6F)
115.  If no, why not?
- 58  -a.  The  loan  is too  small
b.  The  amount  I would  repay  is too much
c.  _  I would  prefer  not to spend more  money  than  I have right  now
d.  _  I don't  believe  that  the bank  would  lend to me
e.  I would  rather borrow  money  from  somewhere  else
f.  Other (please specify):__
6f.  Weekly expenditures
Next I'd like to ask you about things you spend your money on each week.
116.  About how much of your household's food do you grow yourself?
(0) Very  little/none
(1) About  half
(2) Almost  all
(-98)  Don't  know
117. About how much money does your household spend per week on food (not including own production)?
Birr  per week
(-98) Not  Sure
6g. Household  Income
118. How would you classify the economic status of your household relative to others in this village?
____  (2) Much better  than  most  people  (rich)
_  (1) Better  than most  people  (relatively  well off)
(0) About  average
(-1) Below  average  (poor)
_____  (-2) Much  worse  than  average  (very poor)
(-98) Don't  know
119.  What was the off-farm income of all members of this household last year? (Note: Do not include
incomefrom agriculturalproducts  and include rental income if household rents rooms.)
Birr  per  year
(-98) Don't  know
120. Do you receive money from family members or friends who live outside of Ethiopia?
(0) No
(1) Yes
121.  How many quintals of grain did you  produce last year for each of the following crops:
a.  SorghumNo.  of quintals
b.  Finger  millet  No.  of quintals
c.  TeffNo.  of quintals
d.  _  _WheatNo.  of quintals
e.  PulsesNo.  of quintals
f.  Oil cropsNo.  of quintals
g.  OtherNo.  of quintals
122.  Over the next five years, how do you think your household's economic situation will change?
____  (2) Certainly  improve  greatly
____  (1) Probably  improve  somewhat
____  (0) No  change
____  (-1) Probably  decline  somewhat
____  (-2) Certainly  get much  worse
(-98) Don't  Know  / Not  sure
- 59  -Do you agree or disagree; or, are you neutral about the following statements:















(Enumerator: In each category, indicate the number of items owned by the respondent. Ifhousehold  does
not have an item, enter zero.)





128. _  Sheep
129.  _  Oxen
130. _  Other Cattle
131.  Donkey
132.  _  Camel
133.  'Horse
134.  Mule
135.  _  Beehives:
Household Goods:
136.  Kerosene lamp
137.  _  Coleman latem with pump
138.  _  Beds
139.  _  Radio
140.  _  Bicycle




(-95)  )Other  (specify)
142. How old are you?
years
7. Debriefing Questions
- 60  -143.a When I described to you the bednet impregnated with insecticide, I said that it would reduce the
chance of you getting malaria if you used it properly. When you answered the question about purchasing
the bednet, did you assume that this was really possible?
(0) Not at all possible
(l)Assumed it was possible
(-98)Didn't know, not sure not possible
143b.  Now I want you to think about which kind of protection from malaria is more effective. There is no
right or wrong answer, I really want to know what you think. Suppose that you had the choice between a
bednet and a spraying program. Which one would you choose and why?
_  (0) Bednet
_  (1) Spraying program
(-98) Assumed it was possible
143c. Why?
Could you tell me the average price of the following items in this village at the present time?
144.  Charcoal (30-40 kilogram sack)
145. _  _  Goat
146.  _  Sheep
147.  _  Ox
148.  _  Sugar
149.  _  Coffee
150.  Cooking oil (1 liter)
151.  Chicken (live)
152.  _  egg ( 1)
153.  local  beer
154.  local beer
155. _  Bottle of beer
156.  Cola or other soft drink (not imported)
157.  I 1 liter of kerosene
158.  Pack of Cigarettes
159.  10 10 tablets of chloroquine




In this survey, I have asked you if you would be willing to pay for a method to protect you from getting
malaria. As you may know, we are interviewing other people in your community and asking them the same
question. However, some people in your community may have been asked if they would be willing to pay
for the method at a different price than you were asked. We are asking people to respond to different prices
to see how they would respond. Do not worry that you might have been asked a higher or lower price than
someone else who participated in our study.
This is the end of our interview.  Thank you very much for your time and assistance.
161.  Time ended:
FOR ENUMERA TOR ONL Y:
(Enumerator: Do not ask respondent these questions. Observe and answer yourself)
What material(s) were used to build the main house?  (Check all that apply.)
- 61  -162. Walls:
(1) Stone
(2) Wood








(3) Dirt / Mud
(-95)  )Other  (specify)
164. Roof:
(1) Corrugated  iron
(2) Thatching  materials
(3) Wood  and tirnber (local  type)
(4) Mud
(-95)  )Other  (specify)
165. (If the house does have windows) Do any windows have glass panes?
(0) No
(1)  Yes




167. Does the door have a lock?
(0) No
(1)  Yes
Assessment of the interview
168. Was the person who answered the questions irritated or nervous during the interview?
(0) No
(1)  Yes
169. Do you think the respondent made an effort to tell the truth about the willingness-to-pay questions?
(0) No
(1)  Yes




171. How many adults were listening while you conducted this interview with the respondent?
No. of adults
- 62  -Vaccine Scenario
Now I would  like to ask you  what it would be worth  to you to prevent  getting  malaria.  For  many years doctors  have  been
working to develop a vaccine that would prevent people from getting malaria. A vaccine is a medicine that
prevents a person from getting a disease.  A person takes a vaccine before they get sick.
VI.  Has anyone in your household ever received any type of vaccine?
(0) No (SKIP NEXT QUESTION)
(I) Yes
(-98) Don't know/Not sure  (SKIP NEXT QUESTION)
What types of vaccines have they received? (Enumerator.  check all that apply)




Research for a malaria vaccine has not yet been successful; and there may never be a vaccine to protect
against malaria. However, we would like to know what you would do if you could buy such a vaccine.
Imagine that there is a vaccine for malaria even though this is not true.
Assume this vaccine would completely prevent you from getting malaria, and you would not need any
other protection or treatment for malaria. You could have this vaccine as either a pill or injection and both
would be completely effective against malaria.  This means that you would not face the risk of missing
work because of malaria or of having to buy medicine. You would not face the risk of fever or other
symptoms of malaria.
Suppose it was possible for members of your household to get this vaccine. Assume that the government
could not give the vaccine for free, so you would have to buy it.
Now I want to ask you whether your household would buy this vaccine against malariaif it were available
for a price. There is no right or wrong answer. We really want to know what you think. Remember, the
vaccine against malaria would completely prevent you from getting malaria for one year. After one year it
would be necessary to buy and receive another vaccination to prevent getting malaria during the next year.
Some people say that they would not pay for the vaccine because they have more important things to spend
their money on, or because they feel they could prevent malaria in other ways.  For example, they may
spray their homes to kill mosquitoes  or they may sleep under bednets.
This is a bednet [Enumerator: show bednet to respondent].
B 1. Do you normnally  use a bednet?
_(0)  No
(1) Yes (SKIP NEXT QUESTION)
(-98) Don't know (SKIP NEXT QUESTION)
B2. Why not? (Enumerator: Mark first response only.)
(1) Too expensive
(2) Too time consuming/inconvenient
(3) Not applicable to me
(4) Not aware of it
(5) Not available
_  (6) Malaria not a problem where I live
_  (7) Not effective
(-95)  Other: (please specify)
- 63  -Other people say they would not buy the vaccine because they believe the malaria situation here is not so
bad and if they got malaria, they could treat it by taking chloroquine. However, if you bought the vaccine
you would not have to do other things to prevent or treat malaria and you would also avoid the pain and
suffering of the sickness.
V6. Suppose the price of each vaccine against malaria was [5120/40/100/200]  Birr. Would your household
buy one or more vaccines at this price?
(0) No (GO TO QUESTION Vl6)
(1)  Yes
(-98) I don't really know/Not sure (GO TO SECTION 5)
V7. How many vaccinations would your household buy?
______No. of  vaccinations
V8. You said that your household would choose to buy _  vaccinations against malaria at
[5/20/40/100/200] Birr per vaccinations. The vaccinations  would cost your household a total of  Birr.
Could your household really afford to pay this much?
Number of vaccinations
1  2  3  4  5  6  7
Price = 5  5  10  15  20  25  30  35
Price = 20  20  40  60  80  100  120  140
Price = 40  40  80  120  160  200  240  280
Price=  l00  100  200  300  400  500  600  700
Price--200  200  400  600  800  1000  1200  1400
(0) No
(l)  Yes (GO TO VI0)
(-98) Don't know/not sure (GO TO SECTION 5)
V9.How many vaccinations would you buy?
______No. of  vaccinations
VIO.How confident are you that you would really buy this many vaccinations?
(O)  Not at all sure
(1)  Somewhat sure
(2) Very sure
VII  .How many of these vaccinations would be for adults in your household?
Number of vaccinations for adults
V12. How many of these vaccinations would be for teenagers in your household?
Number of vaccinations for teenagers
V 13. How many of these vaccinations would be for children in your household?
Number of vaccinations for children
V14. How would you are members of your household prefer to take the vaccine:  by pill  or by injection?
_______  (1)  By pill
________  (2) By injection
________  (3) Respondent is indifferent  (GO TO SECTION 5)
______  (-98) Don't know (GO TO SECTION 5)
VIS.  Why?
- 64 -GO TO SECTION 5
V 16. How confident are you that you would really not buy the vaccination?
(0) Not at all sure
(1) Somewhat sure
(2) Very sure
VI 7. Why would you not buy the vaccination?  [RECORD RESPONSE.]
[The following  debriefing questions will appear at the end of the questionnaire.]
VI 8. When I described to you the vaccine against malaria, I said that it would be 100 percent effective in
preventing malaria for one year.  When you answered the question about purchasing the vaccine, did you
assume that this was really possible?
(0) Not at all possible
(1) Assumed it was possible.
(-98) Didn't know / Not sure
- 65 -Bednet  Scenario
Now I would like to ask you what it would be worth to you to prevent getting malaria.  One way that
malaria can be prevented is by sleeping under a bednet. This is a bednet [Enumerator: show bednet to
respondent].
B 1. Do you normally use a bednet?
(0) No
(1) Yes ( SKIP B2)
(-98) Don't know/Not sure
B2. Why not? (Enumerator: Mark first response only.)
(1) Too expensive
(2) Too time consuming/inconvenient
(3) Not applicable to me
_  (4) Not aware of it
(5) Not available
(6) Malaria not a problem where I live
(7) Not effective
(-95)  Other: (please specify)
Before I tell you about bednets, I want you to know that we do not have enough bednets to provide them to
people in your village now. However, we are interested in whether people in this village would want to buy
bednets. People hang the nets over their beds in their houses, just like in this picture [Enumerator: show
picture]. By sleeping under the nets at night, people protect themselves from being bitten by mosquitoes
and other insects. The net keeps the mosquitoes away from you. The bednet is even more effective when it
has been soaked with a chemical that kills insects such as mosquitoes, bed bugs, lice and flies that get near
the bednet. The insecticide on these bednets does not harm people and it lasts for about one year.  Once a
year the bednet must be soaked in insecticide again to make it effective. It is also important not to wash the
bednet or the insecticide will be washed off. For bednets to be effective, people must stay under them from
dusk until dawn, which is the time when mosquitoes that carry the malaria parasite are most likely bite.
You may still catch malaria because you may be bitten by a mosquito when you are not under the net.
Do you have any questions?  Yes/No  [Enumerator: Ifyes,  record the question(s) the respondent asked.]
Using a bednet reduces the chances of getting malaria and other diseases. Research in other parts of Africa
has shown that bednets are particularly effective in reducing deaths among children.  For example, in
Kenya it was found that bednets reduced deaths among children by one third.  That means that for every
three children that would have died one was saved when they used bednets soaked in insecticide. It has also
been found that families who use bednets have less sickness and do not have to spend as much money to
prevent and treat malaria. Some households buy only one net and use it for the children. Some households
buy only one net and use it for the adults. Other households buy more than one net. Suppose that people in
your community could buy bednets impregnated with insecticide for a price. Now I want to ask you if your
household would purchase one or more bednets if the Health Bureau were to deliver them to your village.
This does not mean that other community control measures such as spraying insecticides will be stopped.
There is no right or wrong answer; we really want to know what you think. Remember, the bednet will
protect you only when you are sleeping under it. After one year it will be necessary to re-impregnate the
bednet. This will cost about 5 birr each year and the bednet will last about 4 years. Some people say they
would not pay for bednets because they have more important things to spend their money on, or because
they feel they could prevent malaria in other ways. For example, they may take medicine before they get
sick, or they may to spray their homes to try and kill mosquitoes. Other people would not buy bednets
because they believe the malaria situation here is not so bad, and if they got malaria, they could treat it, for
example, by taking chloroquine.  However, if you bought bednets there is a good chance that you would not
get malaria in the first place.  Suppose that the price of a bednet was [8/20/40/100/160] Birr. You would
pay for it in 4 equal payments. You would pay [2/5/10/25/40] Birr per month for 4 months, for a total of
[8/20/40/100/160] Birr.
- 66 -B3. Would your household purchase any bednets if each bednet cost [8/20/40/100/160] Birr?
(0) No(GO TO QUESTION B13)
-____(1)  Yes
(-98) Don't know/not sure (GO TO  SECTION 5)
B4. If yes, how many would your household buy?
No. of bednets
B5. You said that your household would choose to pay for  bednets. At [8/20/40/100/160] Birr per
bednet, the bednets would cost  your household a total of  Birr or 4 equal payments of
Could your household really afford to pay this much?
(0) No
(1) Yes (GO TO B7)
B6. If no, how many bednets would you buy?
No of bednets (if 0, GO TO SECTION 5)
B7. How confident are you that you would really buy this many bednets?
(0) Not sure at all
(1) Somewhat sure
(2) Very sure
B8. How many people in your household would sleep under these bednets?
_No.  of people
B9. How many of these are children?
No. of children
B  10. How many of these are teenagers?
No. of teenagers
B 1  1. How many of these are adults?
No. of adults
(Enumerator: Add the responses to questions B9, B1O,  B]]  and check that the sum is the same as the response to
question B8)
T  otal of questions B9, BIO, B11
B  12. What was the main reason that you decided to buy bednets?
(I) To prevent malaria
(2) To prevent diseases other than malaria
(3) To avoid being bothered by insects and other pests while sleeping
(4) For privacy
(-95)  - Other
B  13. How confident are you that you would really not buy bednets ?
(0) Not sure at all
(1) Somewhat sure
(2) Very sure
B 14. You said you would not be willing to buy a bednet. Please tell me why [enumerator please record
response].
[The following  debriefing question will appear at the end of the questionnaire.]
- 67  -B. When I described to you the bednet impregnated with insecticide, I said that it would reduce the chance
of you getting malaria if you used it properly. When you answered the question about purchasing the
bednet, did you assume that this was really possible?
Not at all possible
Didn't know, not sure not possible
Assumed it was possible
-68  -APPENDIX II. Tables
Table Al.  Means and Standard Deviations of Variables, Vaccine Models
Variable  Obs  Mean  Std. Dev.  Min  Max
Number of nets purchased  569  1.45  2.19  0  10
Price (Birr)  569  68.30  68.22  5  200
Log income (Thousand Birr)  569  2.40  0.84  -1  4
Missing wage (1 if no wage)  569  0.28  0.45  0  1
Number of teenagers  569  0.81  0.91  0  4
Number of children  569  1.95  1.35  0  6
Household dir. cost of illness  569  18.25  16.48  0  68
(Birr)
Married (1 if married)  569  0.82  0.39  0  1
Gender (1 if female)  569  0.53  0.50  0  1
Read (1 if read easily)  569  0.38  0.49  0  1
Age (years)  569  42.56  14.25  17  95
Alt (hundred meters)  569  16.80  1.54  14  19
Household size  569  5.09  2.00  1  11
- 69 -Table Al.  Means and Standard Deviations of Variables, Vaccine Models (continued)
Variable  Obs  Mean  Std. Dev.  Min  Max
HSIZE2  569  0.07  0.25  0  1
HSIZE3  569  0.12  0.32  0  1
HSIZE4  569  0.17  0.38  0  1
HSIZE5  569  0.20  0.40  0  1
HSIZE6  569  0.17  0.37  0  1
HSIZE7  569  0.14  0.34  0  1
HSIZE8  569  0.06  0.24  0  1
HSIZE9  569  0.04  0.21  0  1
Inam_2  569  0.03  0.18  0  1
Inam_3  569  0.04  0.20  0  1
Inam_4  569  0.09  0.29  0  1
Inam_5  569  0.08  0.27  0  1
Inam_6  569  0.09  0.28  0  1
Inam_7  569  0.08  0.27  0  1
Inam_8  569  0.03  0.18  0  1
Inam_9  569  0.04  0.20  0  1
Inam_10  569  0.04  0.19  0  1
Inam_II  569  0.09  0.28  0  1
Inam_12  569  0.04  0.20  0  1
Inam_13  569  0.04  0.19  0  1
Inam_14  569  0.04  0.19  0  1
Inam_16  569  0.04  0.20  0  1
Inam_17  569  0.10  0.30  0  1
Inam_18  569  0.05  0.22  0  1
Inam_19  569  0.04  0.20  0  1
-70 -Table A2. Household Size and Enumerator Effects for Hypothetical Vaccine Models
Variable  Poisson  Negative Binomial  Truncated Poisson
DIhh_2  0.757**  1.000*  0.298
0.382  0.546  0.594
DIhh_3  0.838**  0.887*  -0.106
0.366  0.541  0.581
DIhh_4  1.200**  1.309**  0.218
0.377  0.579  0.588
DIhh_5  1.148**  1.295**  0.110
0.389  0.606  0.592
DIhh_6  1.041**  1.177*  -0.174
0.423  0.685  0.608
DIhh_7  0.677  0.820  -0.684
0.459  0.759  0.623
DIhh_8  1.180**  1.391*  -0.094
0.489  0.833  0.635
DIhh_9  0.927b  1.225  -0.339
0.549  0.947  0.660
Iname_2  -0.368  -0.266  -0.309
0.340  0.520  0.434
Iname_3  0.898**  1.366**  1.689**
0.216  0.424  0.200
Iname_4  -0.799**  -0.833**  -1.043**
0.247  0.397  0.192
Iname_5  -0.608**  -0.600  -0.767**
0.261  0.431  0.221
Iname_6  0.745**  1.298**  1.381**
0.222  0.403  0.185
Iname_7  -0.831**  -0.974**  -0.875**
0.291  0.466  0.222
Iname_8  0.050  0.332  0.122
0.277  0.478  0.268
Iname_9  -0.157  0.090  -0.094
0.281  0.489  0.293
Iname_10  0.662**  0.754*  1.176**
0.254  0.469  0.224
Iname_11  -0.415*  -0.339  -0.526*
0.254  0.416  0.206
Table continued on next page
- 71  -Table A2. Household Size and Enumerator Effects for Hypothetical Vaccine Models
(continued)
Variable  Poisson  Negative Binomial  Truncated Poisson
Iname_12  -0.363  -0.263  -0.324
0.293  0.477  0.248
Iname_13  0.662**  1.039**  1.260*
0.250  0.451  0.211
Iname_14  0.477**  0.818*  0.863**
0.238  0.441  0.192
Iname_16  -1L680**  -1.485**  -1.721**
0.459  0.603  0.338
Iname_17  -0.018  -0.073  0.064
0.236  0.409  0.196
Iname_18  0.055  0.108  0.138
0.268  0.452  0.212
Iname_19  0.541**  1.012**  1.036**
0.239  0.439  0.188
Notes: Standard errors in small font.
**  Significant at the 5% level
Significant at the 10% level
- 72  -Table A3.  Means and Standard Deviations of Variables, Bednet Models
Variable  N  Mean  Std. Dev.  Min  Max
Number of nets purchased  279  1.07  1.14  0  9
Price (Birr)  279  44.89  32.78  8  100
Log income (Thousand Birr)  279  1.97  1.23  -4  4
Missing wage (1 if no wage)  279  0.39  0.49  0  1
Number teenagers  279  0.56  0.78  0  4
Number of children  279  1.74  1.33  0  5
Household cost of illness (Birr)  279  22.26  16.45  0  97
Married (1 if married)  279  0.70  0.46  0  1
Gender (1 if female)  279  0.66  0.47  0  1
Read (1 if read easily)  279  0.53  0.50  0  1
Age (years)  279  41.04  15.04  16  80
Alt (hundred meters)  279  16.51  1.89  12  19
Household size  279  4.53  2.03  1  12
-73 -Table A3.  Means and Standard Deviations of Variables, Bednet Models (continued)
Variable  Obs  Mean  Std. Dev.  Min  Max
HSIZE2  279  .0.13  0.33  0  1
HSIZE3  279  0.15  0.35  0  1
HSIZE4  279  0.21  0.41  0  1
HSIZE5  279  0.18  0.38  0  1
HSIZE6  279  0.12  0.33  0  1
HSIZE7  279  0.11  0.31  0  1
HSIZE8  279  0.04  0.19  0  1
HSIZE9  279  0.03  0.17  0  1
Inam_2  279  0.06  0.24  0  1
Inam_3  279  0.08  0.26  0  1
Ina_n4  279  0.00  0.00  0  0
Inam_5  279  0.00  0.00  0  0
Inam_6  279  0.00  0.00  0  0
Inam_7  279  0.00  0.00  0  0
Ina_n8  279  0.08  0.28  0  1
Inam_9  279  0.09  0.29  0  1
Inam_10  279  0.09  0.28  0  1
Inam_11  279  0.00  0.06  0  1
Inam_12  279  0.08  0.27  0  1
Inami_13  279  0.08  0.27  0  1
Inam_14  279  0.09  0.29  0  1
Inam_16  279  0.08  0.28  0  1
Inami_17  279  0.00  0.06  0  1
Inam_18  279  0.09  0.29  0  1
Inam_ 9  279  0.09  0.28  0  1
- 74 -Table A4. Household Size and Enumerator Effects for Bednet Models
Variable  Poisson  Negative Binomial  Truncated Poisson
DIhh_2  -0.227  -0.227  -0.971
0.446  0.447  0.732
DIhh_3  0.230  0.230  -0.626
0.442  0.443  0.709
DIhh_4  -0.239  -0.239  -1.256
0.482  0.483  0.733
DIhh_5  0.101  0.101  -0.914
0.523  0.523  0.794
DIhh_6  0.367  0.367  -0.628
0.563  0.563  0.866
DIhh_7  0.296  0.296  -0.714
0.641  0.641  0.959
DIhh_8  0.110  0.110  -0.876
0.732  0.730  1,089
DIhh_9  0.885  0.885  -0.039
0.802  0.802  1.192
Iname_2  -0.203  -0.203  -0.202
0.319  0.319  0.409
Iname_3  0.500*  0.500*  0.588*
0.278  0.277  0.347
Iname_8  0.126  0.126  0.126
0.302  0.302  0.373
Iname_9  0.430  0.430  0.439
0.303  0.304  0.386
Iname_10  -0.064  -0.064  -0.123
0.331  0.332  0.430
Iname_12  -0.784**  -0.784*  -0.838**
0.368  0.367  0.408
Iname_13  -0.059  -0.059  -0.090
0.333  0.333  0.460
Inane_14  0.412  0.412b  0.512
0.266  0.266  0.337
Iname_16  -0.916**  -0.916**  -1.052**
0.408  0.407  0.463
Iname_18  -0.135  -0.135  -0.185
0.336  0.337  0.405
Iname_19  -0.032  -0.032  -0.091
0.305  0.305  0.445
Notes: Standard errors in small font.
Significant at the 5% level
Significant at the 10% level
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